{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":57,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":57,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"f341d2f9e313","filters":{"venue":"Clinical Pharmacology in Drug Development"}},"results":[{"id":"W3011153961","doi":"10.1002/cpdd.789","title":"The Bioequivalence of Tafamidis 61‐mg Free Acid Capsules and Tafamidis Meglumine 4 × 20‐mg Capsules in Healthy Volunteers","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Pfizer","keywords":"Medicine; Bioequivalence; Dosing; Tolerability; Pharmacology; Crossover study; Pharmacokinetics; Internal medicine; Placebo; Adverse effect","authors":[{"name":"Peter Lockwood","is_ca":false},{"name":"Vu Le","is_ca":false},{"name":"Melissa O’Gorman","is_ca":false},{"name":"Terrell A. Patterson","is_ca":false},{"name":"Marla B. Sultan","is_ca":false},{"name":"Ekaterina Tankisheva","is_ca":false},{"name":"Qiang Wang","is_ca":false},{"name":"Steve Riley","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03342460266546551,"gpt":0.3503987466890036,"spread":0.3169741440235381,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003495945,0.0009198753,0.001353391,0.0004362974,0.000360444,0.000624784,0.000470646,0.001527372,0.002022579],"category_scores_gemma":[0.003223661,0.0008031015,0.0008131546,0.0003106384,0.0009870257,0.000986559,0.0003686487,0.00110271,0.0007977958],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003227926,"about_ca_system_score_gemma":0.0005053749,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006700127,"about_ca_topic_score_gemma":0.0004990579,"domain_scores_codex":[0.9975211,0.001248065,0.0001771506,0.0005608899,0.000337512,0.000155243],"domain_scores_gemma":[0.9985681,0.0004638801,0.0003266275,0.000239735,0.0001682719,0.000233352],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7641966,0.02135146,0.00628663,0.0004332161,0.0007001832,0.0001700629,0.0008568504,0.0008198224,0.1678689,0.0003110323,0.0006678003,0.03633739],"study_design_scores_gemma":[0.0654442,0.8259242,0.06733806,0.00004614784,0.0009408527,0.0003586251,0.0002496328,0.00507088,0.03183652,0.0003281283,0.002348303,0.000114546],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976719,0.0005248436,0.0006811122,0.00003098511,0.0000745263,0.0004374823,0.0001815052,0.00002518894,0.0003723848],"genre_scores_gemma":[0.9966446,0.0003244568,0.001060001,0.0001351251,0.00009521582,0.000564826,0.0003061537,0.00001561518,0.0008539972],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003495945,"threshold_uncertainty_score":0.01848853,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2793257861","doi":"10.1002/cpdd.439","title":"Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Innovaderm (Canada)","funders":"GlaxoSmithKline","keywords":"Medicine; Tolerability; Pharmacokinetics; Nonsteroidal; Atopic dermatitis; Incidence (geometry); Cohort; Adverse effect; Safety profile; Open label; Pharmacology; Dermatology; Internal medicine","authors":[{"name":"Robert Bissonnette","is_ca":true},{"name":"Lakshmi Vasist","is_ca":false},{"name":"Jonathan Bullman","is_ca":false},{"name":"Therese Collingwood","is_ca":false},{"name":"Geng Chen","is_ca":false},{"name":"Tomoko Maeda‐Chubachi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0443249687538772,"gpt":0.4239657936168991,"spread":0.3796408248630219,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002315795,0.001193772,0.00178285,0.0002369739,0.000501314,0.0007438252,0.0005541684,0.0009514104,0.0029947],"category_scores_gemma":[0.001659182,0.0005184287,0.001033635,0.0002347022,0.0006080261,0.0009772163,0.0002055602,0.00207774,0.0006906297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005059036,"about_ca_system_score_gemma":0.001045902,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005879407,"about_ca_topic_score_gemma":0.001003043,"domain_scores_codex":[0.9992945,0.0003126801,0.00003995064,0.0001319401,0.0001176448,0.0001032791],"domain_scores_gemma":[0.9987137,0.0003098653,0.0002996342,0.0001589862,0.0001891527,0.0003286372],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4230447,0.1326272,0.0192142,0.001197832,0.001824913,0.0006446092,0.0006364679,0.002487312,0.3030241,0.000200919,0.004926592,0.1101713],"study_design_scores_gemma":[0.08146857,0.8403945,0.04896098,0.00003283103,0.0009897861,0.0007183795,0.0001420527,0.001359952,0.02277028,0.0001762097,0.002925728,0.00006063232],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995137,0.0009341231,0.0009118801,0.0001265279,0.00003359928,0.001151592,0.0009865009,0.00006227615,0.0006564397],"genre_scores_gemma":[0.9935154,0.0008415317,0.001527089,0.0003904077,0.0001086846,0.0008766641,0.001534406,0.00003914913,0.001166673],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0029947,"threshold_uncertainty_score":0.0122472,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2889013879","doi":"10.1002/cpdd.608","title":"Pharmacokinetics and Comparative Bioavailability of a Levothyroxine Sodium Oral Solution and Soft Capsule","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Levothyroxine; Bioequivalence; Medicine; Bioavailability; Pharmacokinetics; Crossover study; Randomization; Capsule; Oral administration; Dosage form; Pharmacology; Internal medicine; Randomized controlled trial; Placebo; Hormone","authors":[{"name":"Mario Tanguay","is_ca":true},{"name":"Johanne Girard","is_ca":false},{"name":"Claudia Scarsi","is_ca":false},{"name":"Giuseppe Mautone","is_ca":false},{"name":"Richard Larouche","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2020510462544798,"gpt":0.4820193330155821,"spread":0.2799682867611023,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007504938,0.0003098776,0.000674932,0.000239067,0.0001018438,0.0004029891,0.0002144186,0.0003340486,0.001355982],"category_scores_gemma":[0.001301926,0.0002043533,0.0002603991,0.0002093594,0.0003647681,0.0003865879,0.0001493748,0.0006147426,0.0002655833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001821409,"about_ca_system_score_gemma":0.0002948542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00050891,"about_ca_topic_score_gemma":0.0003216419,"domain_scores_codex":[0.9994611,0.0002385781,0.00003467047,0.00006670759,0.0001583606,0.00004055721],"domain_scores_gemma":[0.9993542,0.0002658892,0.0001370003,0.00006791775,0.00006251888,0.0001124237],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1237474,0.004624088,0.003653872,0.0003995395,0.0003937494,0.0001407458,0.0002595726,0.0009376503,0.7842141,0.0002558311,0.000316315,0.0810572],"study_design_scores_gemma":[0.01242543,0.60423,0.07181733,0.0000448503,0.0007147013,0.0004632091,0.0002153445,0.008779299,0.2973059,0.0001960169,0.00372021,0.00008778992],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973929,0.0009584833,0.001069801,0.000018515,0.00002224555,0.0001206139,0.00008016707,0.00001852343,0.000318779],"genre_scores_gemma":[0.9973169,0.0003364265,0.001334285,0.00003000726,0.0000295764,0.00009876124,0.0001516506,0.000008055098,0.0006943237],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001355982,"threshold_uncertainty_score":0.004536211,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2766447985","doi":"10.1002/cpdd.395","title":"Pharmacokinetics of the BCL‐2 Inhibitor Venetoclax in Healthy Chinese Subjects","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Genentech; AbbVie","keywords":"Venetoclax; Medicine; Pharmacokinetics; Pharmacology; Internal medicine; Oncology; Leukemia","authors":[{"name":"TT Cheung","is_ca":false},{"name":"Ahmed Hamed Salem","is_ca":false},{"name":"Rajeev Menon","is_ca":false},{"name":"Wijith Munasinghe","is_ca":false},{"name":"Orlando F. Bueno","is_ca":false},{"name":"Suresh Agarwal","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05623555057927133,"gpt":0.4560224450009049,"spread":0.3997868944216336,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004985043,0.0002775915,0.0003718361,0.000211049,0.0003707939,0.0002002564,0.0001072901,0.0002381315,0.0007901088],"category_scores_gemma":[0.0007111422,0.0001775881,0.0001584515,0.0002046917,0.0002812594,0.0002069343,0.000113561,0.0002881591,0.0001592705],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003770509,"about_ca_system_score_gemma":0.0004202053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0045776,"about_ca_topic_score_gemma":0.002634374,"domain_scores_codex":[0.9998266,0.00006536007,0.000008763706,0.00003827625,0.00003206086,0.00002890254],"domain_scores_gemma":[0.9997804,0.00006658473,0.00003978519,0.00002384503,0.00003088644,0.00005852453],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0616911,0.003863693,0.6305807,0.0002262354,0.0006694531,0.001209734,0.002124275,0.002522107,0.2189191,0.0002936668,0.001456283,0.07644368],"study_design_scores_gemma":[0.002181455,0.03695443,0.9377269,0.000008425201,0.0004321123,0.000951041,0.0003747983,0.00444572,0.01491653,0.000122294,0.001843247,0.00004308566],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994849,0.0001416563,0.0001226916,0.00001140159,0.000002204028,0.00002190849,0.00004952671,0.000006693755,0.0001590484],"genre_scores_gemma":[0.9992624,0.00007031934,0.0001641633,0.00004705111,0.000006548158,0.00003319826,0.00009494465,0.000001971045,0.000319418],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0045776,"threshold_uncertainty_score":0.009101927,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2606334551","doi":"10.1002/cpdd.358","title":"Single‐ and Multiple‐Dose Pharmacokinetics of Once‐Daily Formulations of Raltegravir","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pharma Medica Research (Canada)","funders":"Merck","keywords":"Raltegravir; Pharmacokinetics; Bioavailability; Pharmacology; Medicine; Biopharmaceutics; Dosing; Biopharmaceutics Classification System; In vivo; Human immunodeficiency virus (HIV); Chemistry; Virology; Antiretroviral therapy; In vitro; Biological activity; Biology; Viral load; Biochemistry; Pharmacognosy; Biotechnology","authors":[{"name":"Rajesh Krishna","is_ca":false},{"name":"Matthew L. Rizk","is_ca":false},{"name":"Patrick Larson","is_ca":false},{"name":"Valerie Schulz","is_ca":false},{"name":"Filippos Kesisoglou","is_ca":false},{"name":"Radu Pop","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08495309511939617,"gpt":0.4174303690147653,"spread":0.3324772738953691,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005575608,0.0002020676,0.0007429885,0.0002133523,0.000116361,0.0003879494,0.0002554237,0.0003341715,0.001259532],"category_scores_gemma":[0.001021953,0.0002239572,0.0002673597,0.0001780917,0.0001557866,0.0004306888,0.0000872899,0.0008350306,0.0002553914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002518448,"about_ca_system_score_gemma":0.000308311,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005040284,"about_ca_topic_score_gemma":0.0004866758,"domain_scores_codex":[0.999713,0.00009372795,0.00001565536,0.00005604694,0.0000978808,0.00002372953],"domain_scores_gemma":[0.9996938,0.00008699556,0.00006449781,0.00004087534,0.00004450478,0.00006944263],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.03274024,0.004253686,0.004773112,0.0001953858,0.0001793887,0.0001423816,0.0002179438,0.001538613,0.825843,0.0002561077,0.000907502,0.1289527],"study_design_scores_gemma":[0.008979698,0.2015217,0.1510135,0.0000619421,0.0005019543,0.002929535,0.0001688422,0.04228984,0.5801092,0.0005133401,0.01174082,0.000169696],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962987,0.0009495897,0.001798621,0.00003277257,0.00002962094,0.0000912887,0.0002074052,0.00008208108,0.0005100318],"genre_scores_gemma":[0.9954305,0.0003893125,0.002753507,0.00004297253,0.00002061247,0.0000988826,0.0003757913,0.0000295099,0.00085891],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001259532,"threshold_uncertainty_score":0.004213572,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4293367557","doi":"10.1002/cpdd.1153","title":"Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton‐Pump Inhibitors","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Bioavailability; Pharmacokinetics; Medicine; Pharmacology; Tolerability; Bioequivalence; Chemistry; Adverse effect","authors":[{"name":"Shringi Sharma","is_ca":false},{"name":"Xavier Pépin","is_ca":false},{"name":"Haran Burri","is_ca":false},{"name":"Lianqing Zheng","is_ca":false},{"name":"Nataliya Kuptsova‐Clarkson","is_ca":false},{"name":"Anouk de Jong","is_ca":false},{"name":"Ting Yu","is_ca":false},{"name":"Holly L. MacArthur","is_ca":true},{"name":"Michał Majewski","is_ca":true},{"name":"John C. Byrd","is_ca":false},{"name":"Richard R. Furman","is_ca":false},{"name":"Joseph A. Ware","is_ca":false},{"name":"James Mann","is_ca":false},{"name":"David A. Ramies","is_ca":false},{"name":"Veerendra Munugalavadla","is_ca":false},{"name":"Louise Sheridan","is_ca":false},{"name":"Helen Tomkinson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2395849207718664,"gpt":0.4805594073694024,"spread":0.240974486597536,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002821132,0.0004100896,0.001179423,0.0003597982,0.0003039278,0.0007774556,0.0004502021,0.0007970409,0.001885996],"category_scores_gemma":[0.002627357,0.0002871786,0.0009953271,0.0005347438,0.0005146195,0.0006194096,0.0002625771,0.001150143,0.0002959266],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004089409,"about_ca_system_score_gemma":0.0006268313,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001045333,"about_ca_topic_score_gemma":0.0007617275,"domain_scores_codex":[0.9976036,0.00126459,0.0001593523,0.0003551893,0.0005139433,0.0001033197],"domain_scores_gemma":[0.9990327,0.0002514012,0.0002989908,0.0001140518,0.0001858878,0.0001168923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2038981,0.01770402,0.006555654,0.001289537,0.001926089,0.0002094518,0.0006637878,0.002636863,0.6686315,0.001021683,0.00135506,0.09410823],"study_design_scores_gemma":[0.02844338,0.7023322,0.05405485,0.0001075887,0.003348733,0.0008522392,0.0002598434,0.01522823,0.1812079,0.0004061494,0.01360899,0.0001499505],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921938,0.001672101,0.003828291,0.0000744069,0.00009907545,0.0008229133,0.0003939824,0.0000546746,0.0008606309],"genre_scores_gemma":[0.9948318,0.0005401553,0.003018276,0.00007673333,0.00006921591,0.0005233607,0.0003087429,0.0000176884,0.0006139355],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002821132,"threshold_uncertainty_score":0.01491976,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2347141072","doi":"10.1002/cpdd.269","title":"Confirmation of Biosimilarity in a Pharmacokinetic/Pharmacodynamic Study in Healthy Volunteers for an Analytically Highly Similar Pegfilgrastim","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Pegfilgrastim; Medicine; Biosimilar; Confidence interval; Pharmacodynamics; Pharmacokinetics; Crossover study; Bioequivalence; Clinical endpoint; Internal medicine; Pharmacology; Surrogate endpoint; Filgrastim; Randomized controlled trial; Granulocyte colony-stimulating factor; Placebo; Chemotherapy","authors":[{"name":"Kalpna Desai","is_ca":true},{"name":"Tina Catalano","is_ca":true},{"name":"Gurinder Rai","is_ca":true},{"name":"Priya Misra","is_ca":true},{"name":"Nirmesh Shah","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08186570106038771,"gpt":0.4648163808401086,"spread":0.3829506797797209,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008162566,0.0006311487,0.0006132097,0.0002659892,0.00043587,0.0006437651,0.0003549727,0.001052762,0.001196852],"category_scores_gemma":[0.007943275,0.0003468372,0.0006095945,0.0001834675,0.0009342729,0.0004039601,0.0003731764,0.001142798,0.0003628914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002595138,"about_ca_system_score_gemma":0.0004990862,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001960248,"about_ca_topic_score_gemma":0.0001581648,"domain_scores_codex":[0.9960964,0.002342284,0.0001881329,0.0005267223,0.000682641,0.0001637831],"domain_scores_gemma":[0.9971595,0.001018508,0.0006664884,0.0004952429,0.0003174404,0.0003428512],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1666177,0.04195549,0.04040014,0.0006808213,0.0007808734,0.0009103917,0.002278327,0.002291273,0.6760379,0.001249816,0.0009830388,0.06581435],"study_design_scores_gemma":[0.02247225,0.8003203,0.09288099,0.00002979919,0.0005595376,0.002177308,0.0002025821,0.006017556,0.07160842,0.0005074701,0.003165085,0.0000586649],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964883,0.0002161537,0.00231538,0.00004184529,0.00002902087,0.0005433912,0.00008436399,0.00001803965,0.000263541],"genre_scores_gemma":[0.9973311,0.00005848431,0.001999567,0.0001111689,0.0000537855,0.0001665786,0.0001407752,0.0000052366,0.0001332835],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008162566,"threshold_uncertainty_score":0.04316831,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3120034421","doi":"10.1002/cpdd.904","title":"Pharmacokinetics and Safety of PTC596, a Novel Tubulin‐Binding Agent, in Subjects With Advanced Solid Tumors","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"PTC Therapeutics","keywords":"Medicine; Pharmacokinetics; Tubulin; Pharmacology; Microtubule","authors":[{"name":"Geoffrey I. Shapiro","is_ca":false},{"name":"Edward O’Mara","is_ca":false},{"name":"Oscar L. Laskin","is_ca":false},{"name":"Lan Gao","is_ca":false},{"name":"John D. Baird","is_ca":false},{"name":"Robert J. Spiegel","is_ca":false},{"name":"Diksha Kaushik","is_ca":false},{"name":"Marla Weetall","is_ca":false},{"name":"Joseph M. Colacino","is_ca":false},{"name":"Kylie O’Keefe","is_ca":false},{"name":"Arthur Branstrom","is_ca":false},{"name":"Elizabeth Goodwin","is_ca":false},{"name":"Jeffrey R. Infante","is_ca":false},{"name":"Philippe L. Bédard","is_ca":true},{"name":"Ronald Kong","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02767090759368996,"gpt":0.3555511339723538,"spread":0.3278802263786638,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003785834,0.0003003528,0.0006574419,0.0001679681,0.0002544638,0.0002831109,0.0001442746,0.0003606885,0.0007304884],"category_scores_gemma":[0.0005247779,0.0001962062,0.0002408699,0.0002321211,0.0002866469,0.0002808893,0.00008503415,0.0008029114,0.0002921483],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003737117,"about_ca_system_score_gemma":0.0004071188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001050645,"about_ca_topic_score_gemma":0.001164741,"domain_scores_codex":[0.9998572,0.0000534322,0.000006844959,0.00002776084,0.00003435711,0.00002044013],"domain_scores_gemma":[0.9997512,0.00005744865,0.00007441609,0.00001497609,0.00003164928,0.00007033267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1370741,0.01214926,0.02873627,0.0004704928,0.0004324345,0.0008812679,0.0007089299,0.003563799,0.6465089,0.0002359566,0.002492623,0.166746],"study_design_scores_gemma":[0.02044823,0.6270453,0.2502892,0.00004350931,0.000755056,0.002376335,0.0002547632,0.008954805,0.07969835,0.000351521,0.009700309,0.00008262201],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978063,0.0009419177,0.0004256175,0.00004100173,0.000009216152,0.0001112067,0.0001646944,0.00003797618,0.0004621171],"genre_scores_gemma":[0.9978123,0.0005663428,0.0004119963,0.00006889741,0.00003152149,0.00007282606,0.000319614,0.00001240871,0.0007040784],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001050645,"threshold_uncertainty_score":0.002711415,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3091934681","doi":"10.1002/cpdd.871","title":"Biopharmaceutical Characteristics of Nifurtimox Tablets for Age‐ and Body Weight‐Adjusted Dosing in Patients With Chagas Disease","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Trypanosoma species research and implications","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Bayer","keywords":"Bioequivalence; Cmax; Medicine; Dosing; Bioavailability; Pharmacology; Confidence interval; Pharmacokinetics; Internal medicine","authors":[{"name":"Heino Staß","is_ca":false},{"name":"Ethel Feleder","is_ca":false},{"name":"Facundo García‐Bournissen","is_ca":true},{"name":"Johannes Nagelschmitz","is_ca":false},{"name":"Boris Weimann","is_ca":false},{"name":"G. Yerino","is_ca":false},{"name":"Jaime Altcheh","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06803022149680939,"gpt":0.3917060144841638,"spread":0.3236757929873544,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009837332,0.0002145282,0.0005205282,0.0002689689,0.0001350856,0.0003094622,0.0001496431,0.0004836498,0.0009163914],"category_scores_gemma":[0.002786091,0.0001247716,0.0004353315,0.0002231498,0.0001606607,0.0002387879,0.00009515241,0.0004104814,0.0001711342],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002027521,"about_ca_system_score_gemma":0.0001884058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003689373,"about_ca_topic_score_gemma":0.0003830814,"domain_scores_codex":[0.9993581,0.0003088472,0.00007446199,0.00007053968,0.0001560121,0.00003194152],"domain_scores_gemma":[0.9987665,0.0005481539,0.0004198328,0.00004670582,0.00009998947,0.0001187701],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.1810546,0.01104429,0.137781,0.001192353,0.001302719,0.00149086,0.0007475389,0.003230044,0.3982372,0.0004651312,0.002200377,0.2612539],"study_design_scores_gemma":[0.01226085,0.2698242,0.6388071,0.00009012928,0.0009398518,0.002476376,0.0002726074,0.008750259,0.06123633,0.0001722172,0.005074958,0.00009505297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971276,0.001538121,0.0005182658,0.00006028868,0.00001726111,0.0001229746,0.000172002,0.000008582877,0.0004349462],"genre_scores_gemma":[0.9983683,0.0002904814,0.0008752193,0.00007061473,0.00002229042,0.000069499,0.0001689516,0.000003080794,0.0001316222],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009837332,"threshold_uncertainty_score":0.005202532,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3113925818","doi":"10.1002/cpdd.894","title":"Comparison of Steroidogenic Exposure Following the Administration of Repository Corticotropin Injection With a Synthetic ACTH<sub>1‐24</sub> Depot and Methylprednisolone in Healthy Subjects","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Depot; Prednisone; Methylprednisolone; Internal medicine; Pharmacodynamics; Subcutaneous injection; Pharmacokinetics; Adrenocorticotropic hormone; Endocrinology; Pharmacology; Hormone","authors":[{"name":"Xiaofeng Wang","is_ca":false},{"name":"Loan Pham","is_ca":false},{"name":"Nagaraju Poola","is_ca":false},{"name":"Leah R. Brooks","is_ca":false},{"name":"Bryan Due","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05146719463994026,"gpt":0.3778594674939645,"spread":0.3263922728540242,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008466024,0.0003787084,0.0004967876,0.0001998608,0.0001286074,0.0003867213,0.0001526354,0.0004356843,0.0006296572],"category_scores_gemma":[0.001334248,0.0002527184,0.0003525107,0.0001514301,0.0002888112,0.0002252999,0.0001259429,0.0004213224,0.000183101],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002477211,"about_ca_system_score_gemma":0.0002766581,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009027248,"about_ca_topic_score_gemma":0.0006306866,"domain_scores_codex":[0.999429,0.000234483,0.00002590486,0.0001042708,0.000159555,0.00004678095],"domain_scores_gemma":[0.9992268,0.0003515829,0.000193789,0.00007154491,0.00004278057,0.0001135125],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.1314604,0.006462461,0.3192565,0.0004177336,0.001545067,0.001498439,0.0007880097,0.006713286,0.447373,0.0002447,0.0007141313,0.08352627],"study_design_scores_gemma":[0.00266378,0.2211243,0.7012432,0.00002345893,0.0007389617,0.002071677,0.0002680097,0.008563947,0.06114061,0.0002024904,0.001906589,0.00005290192],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988726,0.0004112966,0.0003855314,0.00001089778,0.00000567658,0.00003213671,0.00008762532,0.00001304372,0.0001811227],"genre_scores_gemma":[0.9993675,0.00009371334,0.0002139926,0.00003222272,0.00001033309,0.00002579849,0.0001309938,0.000003614493,0.0001218144],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009027248,"threshold_uncertainty_score":0.004477382,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3200515041","doi":"10.1002/cpdd.1020","title":"Pharmacokinetics and Pharmacodynamics of Repository Corticotropin Injection Compared With Synthetic ACTH<sub>1‐24</sub> Depot and Methylprednisolone in Healthy Subjects","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Depot; Medicine; Pharmacodynamics; Adrenocorticotropic hormone; Pharmacokinetics; Methylprednisolone; Internal medicine; Endocrinology; Corticosteroid; Pharmacology; Hormone","authors":[{"name":"Nagaraju Poola","is_ca":false},{"name":"Bryan Due","is_ca":false},{"name":"Dale Wright","is_ca":false},{"name":"Leah R. Brooks","is_ca":false},{"name":"Fahima Zaman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02523109182896986,"gpt":0.3414021503317863,"spread":0.3161710585028165,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009023065,0.0005623341,0.000856346,0.0002189918,0.0002177914,0.0004459705,0.0002235146,0.0006997232,0.00106446],"category_scores_gemma":[0.001484526,0.0004590556,0.0004554789,0.0001581231,0.0005167873,0.0004396107,0.0001379315,0.0007304748,0.0003195934],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002769563,"about_ca_system_score_gemma":0.0003567327,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004972972,"about_ca_topic_score_gemma":0.000439661,"domain_scores_codex":[0.9994283,0.0002676318,0.00002769519,0.0001302364,0.0000855791,0.00006058983],"domain_scores_gemma":[0.9991854,0.0003129873,0.0001686247,0.00005735474,0.00004081584,0.0002347272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7282082,0.01519764,0.03790725,0.0002629405,0.0007930386,0.0004319185,0.000345125,0.001611678,0.1574377,0.0001246796,0.0007057573,0.05697421],"study_design_scores_gemma":[0.05273041,0.752795,0.1687189,0.00001950473,0.0005985133,0.0006685389,0.0001178944,0.00460076,0.01824462,0.0001436664,0.001284817,0.00007736527],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989371,0.000488926,0.0001870659,0.0000220665,0.00001925746,0.00007644141,0.00009248961,0.00001753486,0.0001591141],"genre_scores_gemma":[0.998804,0.0001537444,0.0003480248,0.0000832458,0.00004626045,0.0001029277,0.0001602779,0.000006667877,0.0002948254],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00106446,"threshold_uncertainty_score":0.004771948,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2807342171","doi":"10.1002/cpdd.471","title":"Pharmacokinetic Characteristics of Tofacitinib in Adult Patients With Moderate to Severe Chronic Plaque Psoriasis","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"Pfizer","keywords":"Janus kinase inhibitor; Medicine; Tofacitinib; Dosing; Pharmacokinetics; Psoriasis; Volume of distribution; Renal function; Plaque psoriasis; Internal medicine; Body surface area; Creatinine; Body mass index; Clearance; Gastroenterology; Pharmacology; Urology; Immunology; Rheumatoid arthritis","authors":[{"name":"Guangli Ma","is_ca":false},{"name":"Rujia Xie","is_ca":false},{"name":"Bruce Strober","is_ca":true},{"name":"Richard G. Langley","is_ca":true},{"name":"Kaori Ito","is_ca":false},{"name":"Sriram Krishnaswami","is_ca":false},{"name":"Robert Wołk","is_ca":false},{"name":"Hernán Valdez","is_ca":false},{"name":"Scott T. Rottinghaus","is_ca":false},{"name":"Anna M. Tallman","is_ca":false},{"name":"Pankaj Gupta","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01935625667845373,"gpt":0.303296412492652,"spread":0.2839401558141982,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006154249,0.0002164636,0.0005757896,0.0002186549,0.0001577736,0.0003443727,0.00008373477,0.0002673112,0.0007625463],"category_scores_gemma":[0.002013792,0.000132828,0.000382193,0.0003048338,0.00008874432,0.0002730174,0.000106993,0.0003595323,0.0001735956],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002624184,"about_ca_system_score_gemma":0.0002542912,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001011721,"about_ca_topic_score_gemma":0.0008720467,"domain_scores_codex":[0.9997635,0.00007768705,0.00002587397,0.00005347149,0.00005543356,0.00002398489],"domain_scores_gemma":[0.9993609,0.0003100953,0.0001758443,0.00004166273,0.00004612985,0.00006539433],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007788235,0.0004915036,0.9158036,0.0001276509,0.000615878,0.0009999147,0.0003004207,0.005783884,0.009661449,0.0001887206,0.001110465,0.05712822],"study_design_scores_gemma":[0.0005483956,0.004660387,0.9742508,0.00002447579,0.0003195334,0.003601722,0.0001568921,0.01239374,0.00120972,0.0003753952,0.002431222,0.000027681],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978248,0.0007506157,0.0006493528,0.00003810439,0.000003370248,0.00001957488,0.000297587,0.00001481382,0.0004018506],"genre_scores_gemma":[0.9991459,0.0001866967,0.0002528469,0.00003600624,0.0000101564,0.00001122853,0.0002592492,0.000002107367,0.00009591212],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001011721,"threshold_uncertainty_score":0.003254652,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391745346","doi":"10.1002/cpdd.1379","title":"Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Pfizer","keywords":"Pharmacokinetics; Medicine; Pharmacodynamics; Dosing; Adverse effect; Pharmacology; Discontinuation; Internal medicine; Gastroenterology","authors":[{"name":"Caroline A. Lee","is_ca":false},{"name":"Stefan Schreiber","is_ca":false},{"name":"Brian Bressler","is_ca":true},{"name":"John Adams","is_ca":false},{"name":"D. Alexander Oh","is_ca":false},{"name":"Yong Tang","is_ca":false},{"name":"Jinkun Zhang","is_ca":false},{"name":"Heather Kiyomi Komori","is_ca":false},{"name":"John S. Grundy","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05411766612786526,"gpt":0.4104809408775827,"spread":0.3563632747497174,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001207213,0.0005162315,0.0008241016,0.0001993703,0.0002406046,0.0003466283,0.0001992524,0.00050191,0.001264706],"category_scores_gemma":[0.000981301,0.0002484704,0.0005159449,0.0001821992,0.0003813822,0.0004057933,0.0002173394,0.0007558099,0.0003572178],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001577097,"about_ca_system_score_gemma":0.0002284781,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002206983,"about_ca_topic_score_gemma":0.0003582006,"domain_scores_codex":[0.9995013,0.0001941418,0.00006240787,0.0001059917,0.0001045657,0.00003146945],"domain_scores_gemma":[0.999294,0.000189986,0.0002448738,0.00007731023,0.00007829631,0.00011544],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2555642,0.01927518,0.08309311,0.001357912,0.002721895,0.001026409,0.001053768,0.00172535,0.4191636,0.0001978868,0.001644412,0.2131763],"study_design_scores_gemma":[0.0183625,0.6753013,0.2437613,0.00006237622,0.001823729,0.002576804,0.0002437898,0.001557156,0.04890399,0.0002011119,0.007135259,0.00007067356],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957165,0.00234548,0.0007989859,0.000049596,0.00001697337,0.000160552,0.00031691,0.00002634275,0.0005686543],"genre_scores_gemma":[0.9959016,0.001411203,0.001135796,0.0001901485,0.00006458195,0.0001558258,0.0004864131,0.000008198983,0.0006461731],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001264706,"threshold_uncertainty_score":0.006384432,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2803358008","doi":"10.1002/cpdd.473","title":"Tramadol Hydrochloride at Steady State Lacks Clinically Relevant QTc Interval Increases in Healthy Adults","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Veterinary Pharmacology and Anesthesia","field":"Veterinary","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Tata Consultancy Services; Janssen Research and Development; Janssen Scientific Affairs; Valeant Pharmaceuticals International","keywords":"Medicine; Placebo; Tramadol; QT interval; Anesthesia; Moxifloxacin; Adverse effect; Tramadol Hydrochloride; Crossover study; Nausea; Internal medicine; Analgesic; Antibiotics","authors":[{"name":"Joseph Massarella","is_ca":false},{"name":"Jay Ariyawansa","is_ca":false},{"name":"Jaya Natarajan","is_ca":false},{"name":"Stephan Francke","is_ca":false},{"name":"Thomas Murtaugh","is_ca":false},{"name":"Byron DeLemos","is_ca":false},{"name":"Subusola Vaughan","is_ca":false},{"name":"Sérgio Fonseca","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0815724810782293,"gpt":0.4292402465489839,"spread":0.3476677654707546,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009924023,0.0004201361,0.00102122,0.0001951993,0.0002938179,0.0003209283,0.0002947747,0.0007372115,0.00139811],"category_scores_gemma":[0.001738996,0.0003809166,0.0004450061,0.0001709124,0.0003799955,0.0004923963,0.0002004258,0.000733704,0.0002364174],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001666054,"about_ca_system_score_gemma":0.0003203074,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005090458,"about_ca_topic_score_gemma":0.001274754,"domain_scores_codex":[0.9994735,0.0002158498,0.00006330624,0.0000935554,0.00009741935,0.00005636118],"domain_scores_gemma":[0.9991235,0.0002739127,0.0002987813,0.00005565012,0.0000612323,0.000186874],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4404821,0.022575,0.1037968,0.002486494,0.002092553,0.0013123,0.0007683345,0.0007015431,0.2128213,0.0002344876,0.001293651,0.2114353],"study_design_scores_gemma":[0.07321022,0.5488712,0.3670666,0.00008008182,0.001211036,0.001395294,0.0001613339,0.000706635,0.005436996,0.0001308549,0.00168862,0.00004110133],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962852,0.002869807,0.0001679805,0.00006946625,0.00003598291,0.0001314903,0.00007944668,0.00001449187,0.0003461678],"genre_scores_gemma":[0.9978269,0.001094761,0.0003912835,0.0002234797,0.0000902262,0.00008367103,0.0001044567,0.000002695908,0.0001824296],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00139811,"threshold_uncertainty_score":0.005248368,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2806608475","doi":"10.1002/cpdd.581","title":"Pharmacokinetics of Perampanel in Healthy Korean, White, and Japanese Adult Subjects","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Eisai Canada","keywords":"Medicine; Perampanel; Pharmacokinetics; White (mutation); Pharmacology; Adverse effect; Genetics","authors":[{"name":"Hiroko Tabuchi","is_ca":false},{"name":"Sari Shiba","is_ca":false},{"name":"Sanae Yasuda","is_ca":false},{"name":"Akihiro Ohnishi","is_ca":false},{"name":"Jae‐Gook Shin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05097963392920123,"gpt":0.4227265915702705,"spread":0.3717469576410692,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000274298,0.0003033364,0.0003721432,0.0001907675,0.0002331196,0.0002109506,0.00008139698,0.0001879339,0.0007799865],"category_scores_gemma":[0.0004990094,0.0001878263,0.0001409675,0.0002256531,0.0001636248,0.0002978207,0.000106372,0.00021573,0.000237133],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001599867,"about_ca_system_score_gemma":0.0001290021,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002316322,"about_ca_topic_score_gemma":0.002110026,"domain_scores_codex":[0.9999013,0.00002055736,0.00001011786,0.00003107014,0.00001664461,0.00002020537],"domain_scores_gemma":[0.9998282,0.0000280495,0.00004397173,0.00001495539,0.00002891318,0.0000557834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.03646855,0.003320091,0.7483662,0.000387216,0.0008377591,0.002185053,0.003930443,0.0009834127,0.1277062,0.0004001298,0.001815634,0.07359924],"study_design_scores_gemma":[0.0005891115,0.01261205,0.9794711,0.000007811022,0.0002860356,0.001723021,0.0005587445,0.0008986078,0.001996479,0.00008885924,0.001738749,0.00002944407],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986776,0.0004486222,0.0001736339,0.00001453682,0.000004610387,0.00002579467,0.0001266034,0.000008960837,0.0005197181],"genre_scores_gemma":[0.9985825,0.0003021278,0.0002049499,0.00008847059,0.00000754995,0.00003426524,0.0002270506,0.0000038546,0.0005493528],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002316322,"threshold_uncertainty_score":0.004605651,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4220822477","doi":"10.1002/cpdd.1089","title":"Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed‐Release and Extended‐Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Viron Therapeutics (Canada)","funders":"","keywords":"Pharmacokinetics; Methylphenidate; Bioavailability; Pharmacology; Absorption (acoustics); Morning; Medicine; Crossover study; In vivo; Gastrointestinal tract; Small intestine; Evening; Internal medicine; Attention deficit hyperactivity disorder; Biology; Materials science; Placebo; Psychiatry; Pathology","authors":[{"name":"Bev Incledon","is_ca":false},{"name":"Chantal Incledon","is_ca":false},{"name":"Roberto Goméni","is_ca":false},{"name":"Cassandra Uchida","is_ca":true},{"name":"Amy Morris","is_ca":false},{"name":"Kim Perry","is_ca":false},{"name":"Jill Kapuscinski","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0722415416888,"gpt":0.4134766494053294,"spread":0.3412351077165294,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005279686,0.0004868664,0.0005675658,0.0001474363,0.0001981219,0.0005724372,0.0003114037,0.000387574,0.001270765],"category_scores_gemma":[0.0008874168,0.0003640023,0.0006432738,0.0002389859,0.0002211166,0.0005491598,0.0002425483,0.0008520007,0.0002579503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004967826,"about_ca_system_score_gemma":0.0005842179,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0052143,"about_ca_topic_score_gemma":0.004598923,"domain_scores_codex":[0.9996929,0.00007787419,0.00001747784,0.00006672778,0.00009036114,0.0000546692],"domain_scores_gemma":[0.9994704,0.0002159657,0.0001175415,0.00004287237,0.0001074733,0.00004565725],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01281069,0.0008100407,0.002902117,0.0006982585,0.0002074648,0.0003295116,0.0002025072,0.007839599,0.952849,0.0001958102,0.00042441,0.02073056],"study_design_scores_gemma":[0.0007406893,0.0226558,0.01943877,0.00006381333,0.0006945475,0.0005724624,0.0002434086,0.0587412,0.8900916,0.0001296467,0.006518545,0.0001094229],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926407,0.002592782,0.002883481,0.00009697505,0.0000575677,0.00008939819,0.0005287807,0.00005008333,0.001060373],"genre_scores_gemma":[0.9892358,0.004174274,0.004780544,0.00008273859,0.00002595928,0.00008073213,0.0005138976,0.00004442315,0.001061667],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0052143,"threshold_uncertainty_score":0.01036793,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2158520906","doi":"10.1002/cpdd.189","title":"Effect of lapatinib on oral digoxin absorption in patients","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Cancer Foundation","funders":"GlaxoSmithKline","keywords":"Lapatinib; Digoxin; Medicine; Pharmacokinetics; Pharmacology; Therapeutic index; Oral administration; Drug interaction; Metastatic breast cancer; Absorption (acoustics); Concomitant; Breast cancer; Drug; Internal medicine; Cancer; Trastuzumab; Heart failure","authors":[{"name":"Kevin M. Koch","is_ca":false},{"name":"Deborah A. Smith","is_ca":false},{"name":"Jeff Botbyl","is_ca":false},{"name":"Nikita Arya","is_ca":false},{"name":"Linda P. Briley","is_ca":false},{"name":"Leanne Cartee","is_ca":false},{"name":"Jane Holshouser White","is_ca":false},{"name":"J. Beyer","is_ca":false},{"name":"Mohammed M. Dar","is_ca":false},{"name":"Hyun Choel Chung","is_ca":false},{"name":"Quincy S. Chu","is_ca":true},{"name":"Yung‐Jue Bang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03924627127115151,"gpt":0.3940237622506233,"spread":0.3547774909794718,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004371814,0.0001318766,0.0004567755,0.00009631305,0.000206985,0.0003256888,0.00009589662,0.0002111104,0.001092439],"category_scores_gemma":[0.002398364,0.00008276333,0.0002885038,0.0001578963,0.000118291,0.0002232937,0.0001621505,0.0005264457,0.000124051],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004140178,"about_ca_system_score_gemma":0.0002813326,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007503211,"about_ca_topic_score_gemma":0.00139106,"domain_scores_codex":[0.9996765,0.0001382813,0.00002483019,0.00004473481,0.00006610784,0.00004961525],"domain_scores_gemma":[0.9992601,0.0003422291,0.0001818019,0.00003145324,0.00005264907,0.0001317919],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.09793171,0.002588508,0.5123551,0.0003101886,0.0008873295,0.002647671,0.0005726596,0.001211661,0.03244014,0.0002150995,0.002140251,0.3466997],"study_design_scores_gemma":[0.003123806,0.0806368,0.8870918,0.00005748918,0.0008864992,0.004897143,0.000353927,0.00230965,0.01200442,0.0001826217,0.008420847,0.0000349873],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959929,0.001852022,0.00009071004,0.0001552189,0.00001142436,0.00001963258,0.00007781049,0.000009148119,0.001791188],"genre_scores_gemma":[0.9990461,0.0003222915,0.00008834907,0.0001376241,0.00001856783,0.000007614179,0.00007935042,0.000002528026,0.0002974879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001092439,"threshold_uncertainty_score":0.00365454,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2945178990","doi":"10.1002/cpdd.699","title":"Evaluation of the Pharmacokinetic Interaction Between Doravirine and Methadone","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Methadone; Medicine; Pharmacokinetics; Dosing; Confidence interval; Pharmacology; Drug interaction; Methadone maintenance; Internal medicine","authors":[{"name":"Sauzanne Khalilieh","is_ca":false},{"name":"Ka Lai Yee","is_ca":false},{"name":"Rosa I. Sánchez","is_ca":false},{"name":"Kate Vaynshteyn","is_ca":false},{"name":"Fan Li","is_ca":false},{"name":"Shawn Searle","is_ca":false},{"name":"Mohammed Bouhajib","is_ca":true},{"name":"Marian Iwamoto","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08319404251493585,"gpt":0.4393486597931239,"spread":0.356154617278188,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002205072,0.0003286767,0.000585177,0.0002069638,0.0001590045,0.0004825571,0.0002521737,0.000359773,0.0007998263],"category_scores_gemma":[0.004879679,0.000241079,0.0004337351,0.0001744502,0.0001581084,0.0002982509,0.0002052199,0.0004852923,0.0001192017],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000395763,"about_ca_system_score_gemma":0.0004113023,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009181267,"about_ca_topic_score_gemma":0.001258638,"domain_scores_codex":[0.9979346,0.001094379,0.0000614275,0.0002169751,0.0006228869,0.00006983268],"domain_scores_gemma":[0.997973,0.0009026451,0.0006147579,0.0001069664,0.0002629476,0.0001396879],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06646635,0.007032078,0.3820964,0.0008648501,0.004197658,0.0007391415,0.0009452548,0.006123679,0.3537882,0.0004625891,0.00088444,0.1763994],"study_design_scores_gemma":[0.002807016,0.1385766,0.7119,0.00005930909,0.001637938,0.003058347,0.0004053385,0.04557396,0.09136352,0.0002416099,0.004261762,0.0001147044],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976535,0.000689358,0.001029305,0.00002480799,0.000006935324,0.00008532014,0.00010636,0.00001527825,0.0003891237],"genre_scores_gemma":[0.9982064,0.0002141775,0.001113515,0.00003901888,0.00001022283,0.00004023187,0.0001039621,0.000006258668,0.0002662866],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002205072,"threshold_uncertainty_score":0.01166171,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2981182356","doi":"10.1002/cpdd.747","title":"A Pharmacokinetic Bioequivalence Study Comparing Sublingual Riluzole (BHV‐0223) and Oral Tablet Formulation of Riluzole in Healthy Volunteers","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Biohaven Pharmaceuticals","keywords":"Bioequivalence; Riluzole; Medicine; Pharmacokinetics; Geometric mean; Confidence interval; Adverse effect; Area under the curve; Sublingual administration; Pharmacology; Internal medicine; Amyotrophic lateral sclerosis; Mathematics","authors":[{"name":"Irfan Qureshi","is_ca":false},{"name":"Meghan Lovegren","is_ca":false},{"name":"Victoria Wirtz","is_ca":false},{"name":"Richard Larouche","is_ca":false},{"name":"Mario Tanguay","is_ca":true},{"name":"Matt S. Anderson","is_ca":false},{"name":"Sonja Hartmann","is_ca":false},{"name":"Vlad Coric","is_ca":false},{"name":"Robert Berman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08764181574720296,"gpt":0.4492870065205536,"spread":0.3616451907733506,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001653867,0.0005414562,0.0008437257,0.0002167357,0.0002573355,0.0004107489,0.0002260118,0.0007426537,0.001058124],"category_scores_gemma":[0.001411327,0.0003173596,0.0004352906,0.0001964202,0.0004509881,0.0003733665,0.0001921482,0.0005586545,0.0003287237],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002766117,"about_ca_system_score_gemma":0.0003669523,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001321505,"about_ca_topic_score_gemma":0.0007761202,"domain_scores_codex":[0.999134,0.0004590991,0.00004551366,0.0001690104,0.000130602,0.00006175441],"domain_scores_gemma":[0.9995291,0.0001227,0.0001081392,0.00007439878,0.00006543092,0.000100168],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3639568,0.01767039,0.03582193,0.0005432628,0.001607083,0.0003575954,0.001932245,0.001642698,0.4739794,0.0005380633,0.0009864131,0.100964],"study_design_scores_gemma":[0.02891531,0.619845,0.2846734,0.00003547118,0.001271648,0.0009926152,0.0005881396,0.009818471,0.04990754,0.0002702368,0.003544582,0.0001376418],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989587,0.0002729901,0.0004197216,0.00001058949,0.00001132795,0.0001145178,0.00006332283,0.00001145772,0.0001374049],"genre_scores_gemma":[0.998807,0.0001430238,0.0005229869,0.00004002826,0.00001685205,0.0001012857,0.0001118583,0.000004879515,0.0002520921],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001653867,"threshold_uncertainty_score":0.008746564,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391607838","doi":"10.1002/cpdd.1383","title":"Pharmacokinetics and Pharmacodynamics of Etripamil, an Intranasally Administered, Fast‐Acting, Nondihydropyridine Calcium Channel Blocker","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Altasciences (Canada); Vertex Pharmaceuticals (Canada); Cégep de Saint-Laurent","funders":"","keywords":"Medicine; Pharmacodynamics; Calcium channel blocker; Pharmacokinetics; Nasal administration; Pharmacology; Calcium channel; Anesthesia; Calcium; Internal medicine","authors":[{"name":"James E. Ip","is_ca":false},{"name":"Douglas Wight","is_ca":true},{"name":"Corinne Seng Yue","is_ca":false},{"name":"David H. Nguyen","is_ca":true},{"name":"Francis Plat","is_ca":true},{"name":"Bruce S. Stambler","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03845254996460452,"gpt":0.3985359675126638,"spread":0.3600834175480593,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005226072,0.0002432412,0.0004590334,0.0001009617,0.0001068888,0.0002087817,0.0001270126,0.0002556791,0.0005977816],"category_scores_gemma":[0.0008984224,0.0002027376,0.0002580605,0.0001077197,0.0002100164,0.0003688944,0.00007811237,0.000494864,0.0001575895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001395871,"about_ca_system_score_gemma":0.0001896353,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003418731,"about_ca_topic_score_gemma":0.000468722,"domain_scores_codex":[0.9997587,0.0001140456,0.00001933874,0.00004146072,0.00004796637,0.0000185826],"domain_scores_gemma":[0.9996593,0.0001219642,0.0001063399,0.00003996854,0.000030207,0.00004236255],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.05481933,0.002856647,0.02157162,0.000342535,0.0004299828,0.0003826115,0.0004392075,0.00155274,0.8081142,0.0001283897,0.0006042033,0.1087585],"study_design_scores_gemma":[0.01446687,0.4115135,0.3637037,0.00003052572,0.0009650906,0.00257722,0.0002142061,0.008072441,0.1928492,0.0002343201,0.005291439,0.00008132619],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975654,0.0007625234,0.001076545,0.000030295,0.000007729828,0.00009225767,0.0001606083,0.000020693,0.0002839588],"genre_scores_gemma":[0.9965061,0.000517924,0.001961094,0.00007991266,0.00003762939,0.0001630019,0.0002809208,0.00001019612,0.0004431993],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0005977816,"threshold_uncertainty_score":0.002763867,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2937154946","doi":"10.1002/cpdd.685","title":"Evaluation of the Pharmacokinetics of Metformin Following Coadministration With Doravirine in Healthy Volunteers","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Medicine; Pharmacokinetics; Pharmacology; Metformin; Pharmacokinetic interaction; Drug interaction; Internal medicine","authors":[{"name":"Rosa I. Sánchez","is_ca":false},{"name":"Ka Lai Yee","is_ca":false},{"name":"Fan Li","is_ca":false},{"name":"Dawn Cislak","is_ca":false},{"name":"Maureen Martell","is_ca":true},{"name":"Heather R. Jordan","is_ca":true},{"name":"Marian Iwamoto","is_ca":false},{"name":"Sauzanne Khalilieh","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05189335607255027,"gpt":0.4140086072678435,"spread":0.3621152511952932,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00157107,0.0006364168,0.0009420647,0.0002527324,0.0004486717,0.000427992,0.0002271083,0.0006460358,0.00120774],"category_scores_gemma":[0.002691474,0.0004047859,0.0004660351,0.0002185553,0.0002864272,0.0004755192,0.0002766066,0.000651984,0.0003111867],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002707237,"about_ca_system_score_gemma":0.0003453556,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006108715,"about_ca_topic_score_gemma":0.0006214808,"domain_scores_codex":[0.9991074,0.0004016653,0.00004458638,0.0002202796,0.0001661601,0.00005987772],"domain_scores_gemma":[0.9990543,0.0002467542,0.0002433567,0.00009751797,0.0001333833,0.0002248167],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4848373,0.01992939,0.2388357,0.0004555899,0.001228465,0.0006979828,0.0009524771,0.001313438,0.1593231,0.0001191641,0.0009674478,0.09133999],"study_design_scores_gemma":[0.01142426,0.4018269,0.5522329,0.00002927186,0.001076582,0.001119238,0.0003435123,0.004964069,0.02458481,0.0001066186,0.0022124,0.00007947374],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988386,0.0002846734,0.0002961248,0.00001413111,0.00001886367,0.000156437,0.000115621,0.00001589517,0.0002596694],"genre_scores_gemma":[0.9986477,0.00009235822,0.0005582184,0.00005407993,0.00002507868,0.00011407,0.0001386506,0.000005252803,0.0003645241],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00157107,"threshold_uncertainty_score":0.008308709,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3215986232","doi":"10.1002/cpdd.1043","title":"The Effect of Oral Letermovir Administration on the Pharmacokinetics of a Single Oral Dose of P‐Glycoprotein Substrate Digoxin in Healthy Volunteers","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Digoxin; Medicine; Pharmacokinetics; Pharmacology; Tolerability; Oral administration; Crossover study; Internal medicine; Placebo; Adverse effect; Heart failure","authors":[{"name":"Jürgen Scheuenpflug","is_ca":false},{"name":"Dirk Kropeit","is_ca":false},{"name":"Katharina Erb‐Zohar","is_ca":false},{"name":"Jochen G.W. Theis","is_ca":false},{"name":"Hans‐Peter Stobernack","is_ca":false},{"name":"David McCormick","is_ca":false},{"name":"Holger Zimmermann","is_ca":false},{"name":"Helga Rübsamen‐Schaeff","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07222058166040611,"gpt":0.4252310117062345,"spread":0.3530104300458284,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001047766,0.0008493169,0.001346198,0.0001989191,0.0003874628,0.0005785159,0.0002563582,0.0009093999,0.001374376],"category_scores_gemma":[0.001887188,0.000536853,0.0004227331,0.000159619,0.000589561,0.0004520204,0.000286172,0.001011632,0.0004511231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002676157,"about_ca_system_score_gemma":0.000497295,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008322797,"about_ca_topic_score_gemma":0.0008475169,"domain_scores_codex":[0.9992613,0.0003200455,0.00003513341,0.0002070462,0.00007562005,0.0001007692],"domain_scores_gemma":[0.9992381,0.0002542813,0.000108249,0.00007871583,0.00007285192,0.0002476919],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.6252139,0.02575598,0.0146557,0.0003469055,0.0004309259,0.0006989056,0.0006648246,0.0007554918,0.25972,0.00009830292,0.0008868635,0.07077212],"study_design_scores_gemma":[0.0166501,0.8485835,0.09226369,0.00002334385,0.0005368083,0.0006736588,0.0001833879,0.002301798,0.03680132,0.0001538325,0.001755609,0.00007306147],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984735,0.0004727457,0.0002387518,0.00002848646,0.00003916108,0.0001805928,0.0001016009,0.00002479364,0.0004404166],"genre_scores_gemma":[0.9978685,0.0003317468,0.0004563431,0.00009647986,0.00008144394,0.0001832761,0.0001941582,0.00001555781,0.0007725404],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001374376,"threshold_uncertainty_score":0.005541146,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3133802300","doi":"10.1002/cpdd.926","title":"Pharmacokinetic Interaction Among Ezetimibe, Rosuvastatin, and Telmisartan","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Medicine; Telmisartan; Rosuvastatin; Ezetimibe; Pharmacokinetic interaction; Pharmacology; Pharmacokinetics; Internal medicine; Drug interaction; Statin; Blood pressure","authors":[{"name":"Ki Young Huh","is_ca":false},{"name":"Sang Won Lee","is_ca":true},{"name":"Kyung Tae Kim","is_ca":true},{"name":"In‐Jin Jang","is_ca":false},{"name":"Seung‐Hwan Lee","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03683423971864972,"gpt":0.3937161031873667,"spread":0.356881863468717,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002321643,0.0005280345,0.0016093,0.0002695352,0.0001771884,0.0005620841,0.0003068486,0.0005626839,0.001227791],"category_scores_gemma":[0.002342454,0.0003665658,0.0008595224,0.000226227,0.0004506072,0.0005590644,0.0001761531,0.001007462,0.0001711601],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004060738,"about_ca_system_score_gemma":0.0003874601,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004021255,"about_ca_topic_score_gemma":0.0004938547,"domain_scores_codex":[0.9980521,0.001203953,0.00009172214,0.0002089515,0.0003479449,0.00009534082],"domain_scores_gemma":[0.9985659,0.0006300879,0.0004079429,0.0001070259,0.00007430625,0.0002148204],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.7374833,0.007194431,0.06032937,0.0005299331,0.005369873,0.0004064909,0.0001801386,0.002402876,0.1173866,0.0002674269,0.0004387382,0.06801092],"study_design_scores_gemma":[0.1032339,0.4322303,0.3874968,0.00004560396,0.006644469,0.00119182,0.000209255,0.02060576,0.04473842,0.0007936745,0.002695084,0.0001148223],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963661,0.001973376,0.00101499,0.00006806695,0.00003344966,0.0001201017,0.0001111892,0.00002981567,0.0002826535],"genre_scores_gemma":[0.9987311,0.0002552188,0.0006243542,0.00005774525,0.0000460755,0.00004435613,0.00006742823,0.000004684711,0.0001690243],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002321643,"threshold_uncertainty_score":0.0122782,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2992701293","doi":"10.1002/cpdd.753","title":"Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodeficiency","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Montreal Clinical Research Institute; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Dosing; Primary immunodeficiency; Pharmacokinetics; Intensive care medicine; Pharmacology; Internal medicine","authors":[{"name":"Mikhail Rojavin","is_ca":false},{"name":"Hugo Chapdelaine","is_ca":true},{"name":"Michael A. Tortorici","is_ca":false},{"name":"Michaela Praus","is_ca":false},{"name":"Gautam Baheti","is_ca":false},{"name":"Ying Zhang","is_ca":false},{"name":"Jutta Hofmann","is_ca":false},{"name":"Roxane Labrosse","is_ca":true},{"name":"Renée Dicaire","is_ca":true},{"name":"Élie Haddad","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01322076693013418,"gpt":0.2940168658577188,"spread":0.2807960989275846,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001324067,0.0002694237,0.000711024,0.0002077781,0.0001680885,0.0006245652,0.0001632997,0.0003950527,0.000737837],"category_scores_gemma":[0.003781194,0.0001947153,0.0003283491,0.000244014,0.0002357758,0.000458369,0.0002104139,0.0007889652,0.0001926774],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003932407,"about_ca_system_score_gemma":0.0002962665,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004331738,"about_ca_topic_score_gemma":0.0002862833,"domain_scores_codex":[0.9992529,0.0003659271,0.00003957414,0.0001274826,0.0001585136,0.00005561944],"domain_scores_gemma":[0.9982322,0.0008196406,0.0004501017,0.0001291357,0.00008292485,0.0002860693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1799995,0.004364838,0.391307,0.0005138913,0.00160555,0.001408364,0.001172025,0.01154369,0.1297801,0.0005183156,0.002269622,0.2755171],"study_design_scores_gemma":[0.007117324,0.2055352,0.733507,0.00005882797,0.0007682162,0.003789992,0.0002889719,0.02754909,0.01623348,0.000524313,0.004538301,0.00008928306],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977539,0.0008145981,0.0007620208,0.00005260225,0.00000879138,0.00003460188,0.0001017225,0.00002558068,0.0004461267],"genre_scores_gemma":[0.9994096,0.00008535311,0.0002565872,0.00004240799,0.000009520923,0.00001981362,0.0000754791,0.000002917268,0.00009837103],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001324067,"threshold_uncertainty_score":0.007002473,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2906348647","doi":"10.1002/cpdd.643","title":"Effect of Rifampicin on the Pharmacokinetics of a Single Dose of Vemurafenib in Patients With <i>BRAF</i> <sup>V600</sup> Mutation–Positive Metastatic Malignancy","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Vemurafenib; Medicine; Pharmacokinetics; Pharmacology; Area under the curve; Dosing; Rifampicin; Confidence interval; Internal medicine; Gastroenterology; Urology; Metastatic melanoma; Cancer; Pathology; Tuberculosis","authors":[{"name":"Weijiang Zhang","is_ca":false},{"name":"Christine McIntyre","is_ca":false},{"name":"Harper Forbes","is_ca":true},{"name":"Rabab Gaafar","is_ca":false},{"name":"Hanaa M Kohail","is_ca":false},{"name":"J. Thaddeus Beck","is_ca":false},{"name":"Stjepko Pleština","is_ca":false},{"name":"E. Bertrán","is_ca":false},{"name":"Todd Riehl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01646367025858358,"gpt":0.3114050173212828,"spread":0.2949413470626992,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008033128,0.0003819535,0.0009479233,0.0001547932,0.0002186019,0.000391609,0.0001552445,0.0003055379,0.0007084764],"category_scores_gemma":[0.002150441,0.0002246623,0.0006276608,0.0001194972,0.0002755493,0.0002946853,0.0001484895,0.0009873478,0.000155023],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004569795,"about_ca_system_score_gemma":0.0003654947,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004279701,"about_ca_topic_score_gemma":0.0006842672,"domain_scores_codex":[0.999576,0.0002204822,0.00002620617,0.00007475661,0.00005320045,0.00004938378],"domain_scores_gemma":[0.9988917,0.0003650251,0.0003151656,0.00006704398,0.00005636717,0.0003047773],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.398461,0.01282113,0.1672829,0.0002844128,0.001985348,0.001331119,0.0005591789,0.006161936,0.1992858,0.0001637105,0.002407926,0.2092556],"study_design_scores_gemma":[0.03091265,0.4417844,0.4745885,0.00004571512,0.00102788,0.002774087,0.0002258157,0.01036055,0.03507018,0.0001878903,0.002943017,0.00007940912],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989377,0.0005157358,0.0001596791,0.00007364095,0.00001595729,0.00002679951,0.00003603528,0.00001772901,0.0002167264],"genre_scores_gemma":[0.9996227,0.00007683406,0.0001230415,0.00003534857,0.00001895325,0.00001093544,0.00004503757,0.00000271844,0.00006448486],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009479233,"threshold_uncertainty_score":0.004248321,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2888696165","doi":"10.1002/cpdd.607","title":"Assessment of the Effects of Age and Renal Function on Pharmacokinetics of Bazedoxifene in Postmenopausal Women","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"Pfizer","keywords":"Medicine; Pharmacokinetics; Renal function; Selective estrogen receptor modulator; Placebo; Internal medicine; Osteoporosis; Impaired renal function; Postmenopausal women; Urology; Estrogen receptor; Cancer","authors":[{"name":"William McKeand","is_ca":false},{"name":"James Ermer","is_ca":true},{"name":"Joan Korth‐Bradley","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008928351467708354,"gpt":0.3344801991064224,"spread":0.325551847638714,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007765172,0.0002019934,0.00041279,0.0002129292,0.0001762205,0.000242246,0.00008513509,0.0002796004,0.0006013726],"category_scores_gemma":[0.001698438,0.0001978079,0.000216033,0.000175641,0.000145017,0.0001877351,0.0001375974,0.0002408231,0.0001176484],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001236528,"about_ca_system_score_gemma":0.0001742977,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001081128,"about_ca_topic_score_gemma":0.00123425,"domain_scores_codex":[0.9996612,0.0001829079,0.00001613163,0.00003546572,0.00007986206,0.00002451319],"domain_scores_gemma":[0.9994534,0.0002011778,0.0001686435,0.00004191468,0.00005645387,0.00007842718],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05107223,0.00107489,0.7993885,0.000180502,0.0005857499,0.0004590306,0.0004917207,0.0004891605,0.1057407,0.0000861929,0.0002703684,0.04016095],"study_design_scores_gemma":[0.0003411084,0.01112718,0.9808142,0.000006016247,0.0002405589,0.0005108601,0.00009024642,0.0006111083,0.005462622,0.00003994545,0.0007454392,0.00001062701],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981192,0.001301484,0.0001489227,0.00001866407,0.00000421171,0.00001663833,0.00007565027,0.000005903401,0.0003093198],"genre_scores_gemma":[0.9992767,0.0002944289,0.0001235701,0.00002908851,0.000008922615,0.00001247772,0.00004832005,0.000001748556,0.0002047838],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001081128,"threshold_uncertainty_score":0.004106641,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4400593447","doi":"10.1002/cpdd.1436","title":"Food Effect and Pharmacokinetic Bridging of Avacopan in Caucasian and Japanese Healthy Participants","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Medicine; Pharmacokinetics; Crossover study; Placebo; Internal medicine; Tolerability; Area under the curve; Oral administration; Gastroenterology; Randomized controlled trial; Pharmacology; Adverse effect; Pathology","authors":[{"name":"Shichang Miao","is_ca":false},{"name":"Pirow Bekker","is_ca":false},{"name":"Danielle Armas","is_ca":false},{"name":"Mary Lor","is_ca":true},{"name":"Ryuzo Hanada","is_ca":false},{"name":"Shota Okamura","is_ca":false},{"name":"Yuko Umezawa","is_ca":false},{"name":"Ashit Trivedi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03734745860357723,"gpt":0.4049165509674602,"spread":0.367569092363883,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001094972,0.0004633704,0.0007105542,0.0002152218,0.0006544589,0.0003122069,0.0001850602,0.0005706297,0.001825709],"category_scores_gemma":[0.001310294,0.0003291555,0.000535792,0.0002228989,0.0003500536,0.0003401383,0.0002552543,0.0004711908,0.0003277958],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002437206,"about_ca_system_score_gemma":0.0003339702,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002859116,"about_ca_topic_score_gemma":0.003347214,"domain_scores_codex":[0.9995435,0.0001470823,0.0000368554,0.0001471025,0.00005595995,0.00006941796],"domain_scores_gemma":[0.9994493,0.00008015909,0.0001274369,0.00006529728,0.00009496976,0.0001828285],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.3486967,0.01151151,0.4447294,0.0008548824,0.0022926,0.001359758,0.005294506,0.0003898815,0.1315468,0.0002542307,0.002109682,0.05096018],"study_design_scores_gemma":[0.009016111,0.06573405,0.9138623,0.0000239518,0.0015791,0.0007590702,0.000897,0.0006994943,0.003635965,0.0001161195,0.003600769,0.00007604362],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991719,0.0002464773,0.00008799228,0.00001882936,0.00001050068,0.00006108956,0.0001051231,0.000004559221,0.0002935491],"genre_scores_gemma":[0.9988109,0.00009349131,0.0002328214,0.0001237508,0.00001564665,0.0001131523,0.000171026,0.00000416156,0.000435084],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002859116,"threshold_uncertainty_score":0.006107628,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3008901859","doi":"10.1002/cpdd.773","title":"Absolute Bioavailability of Vemurafenib in Patients With <i>BRAF</i><sup>V600</sup> Mutation–Positive Malignancies","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"","keywords":"Vemurafenib; Medicine; Bioavailability; Mutation; Internal medicine; Cancer research; Oncology; Pharmacology; Cancer; Genetics; Metastatic melanoma; Gene","authors":[{"name":"Weijiang Zhang","is_ca":false},{"name":"Dawn Colburn","is_ca":false},{"name":"Brian Simmons","is_ca":false},{"name":"Zsuzsanna Pápai","is_ca":false},{"name":"Enric Bertran","is_ca":false},{"name":"Simone Schadt","is_ca":false},{"name":"Christophe Husser","is_ca":false},{"name":"Harper Forbes","is_ca":true},{"name":"Dieter Roethlisberger","is_ca":false},{"name":"Thomas Härtung","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01810976022212002,"gpt":0.2810174184975781,"spread":0.262907658275458,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004212505,0.0002836412,0.0007420141,0.000146304,0.000213611,0.0003299957,0.0001261436,0.0002934747,0.0007953274],"category_scores_gemma":[0.0007670475,0.0001996615,0.0002823526,0.0000909779,0.0001526916,0.0003532367,0.0001463876,0.0005784933,0.0001879411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003006304,"about_ca_system_score_gemma":0.0002452256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004366798,"about_ca_topic_score_gemma":0.0003909988,"domain_scores_codex":[0.9998367,0.00005827452,0.00001002276,0.0000427955,0.00002647464,0.0000256926],"domain_scores_gemma":[0.999686,0.00009615094,0.0001083051,0.00001643183,0.00002514465,0.00006794431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1602334,0.005074006,0.3611588,0.0002784719,0.0006235663,0.001316688,0.0005076496,0.004577148,0.3502855,0.0001996797,0.00186648,0.1138786],"study_design_scores_gemma":[0.01056561,0.1758416,0.7305996,0.00003345158,0.0007995759,0.003811913,0.0002529428,0.01251976,0.06034199,0.000294458,0.004856795,0.00008227774],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990934,0.0003550355,0.0002410755,0.00002626155,0.000004020368,0.00002316339,0.00005693867,0.00001532747,0.0001847854],"genre_scores_gemma":[0.9994041,0.00007420687,0.0001818408,0.00004147214,0.00001001628,0.00001893058,0.000118061,0.000003434974,0.0001479416],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007953274,"threshold_uncertainty_score":0.002660632,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4390599050","doi":"10.1002/cpdd.1364","title":"Effect of Tacrolimus Formulation (Prolonged‐Release vs Immediate‐Release) on Its Susceptibility to Drug‐Drug Interactions with St. John's Wort","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"CYP3A; CYP3A4; Tacrolimus; Pharmacology; Medicine; Pharmacokinetics; Drug interaction; CYP3A5; Calcineurin; Crossover study; P-glycoprotein; Pharmacokinetic interaction; Cmax; Inducer; Cytochrome P450; Internal medicine; Metabolism; Chemistry; Transplantation; Antibiotics; Biochemistry","authors":[{"name":"Katja S. Gümüs","is_ca":false},{"name":"Anna Teegelbekkers","is_ca":false},{"name":"Max Sauter","is_ca":false},{"name":"Andreas D. Meid","is_ca":false},{"name":"Jürgen Burhenne","is_ca":false},{"name":"Johanna Weiß","is_ca":false},{"name":"Antje Blank","is_ca":false},{"name":"Walter E. Haefeli","is_ca":false},{"name":"David Czock","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07446660461163242,"gpt":0.4725914293935504,"spread":0.398124824781918,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007636131,0.0003884705,0.00096276,0.0001692579,0.0001248496,0.000409741,0.0002211322,0.0005298137,0.001723986],"category_scores_gemma":[0.001951106,0.0001975851,0.0005752035,0.0002165432,0.0002824328,0.0003619612,0.000125998,0.0005936159,0.0003039293],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000160291,"about_ca_system_score_gemma":0.0001599194,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002226349,"about_ca_topic_score_gemma":0.0002310786,"domain_scores_codex":[0.9992641,0.0003312936,0.0000731702,0.0001332806,0.0001217236,0.00007641912],"domain_scores_gemma":[0.998955,0.0004644291,0.0002731781,0.00007893224,0.00006569481,0.0001627189],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5711684,0.008583002,0.004641489,0.0006172893,0.0008962883,0.0001896202,0.0001306981,0.0008130812,0.3294627,0.00009533649,0.0004261311,0.08297601],"study_design_scores_gemma":[0.02612147,0.7310467,0.09082536,0.00005582637,0.001696897,0.0006969474,0.00008154759,0.003845343,0.1432824,0.0000753328,0.002188061,0.0000841427],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998185,0.001182244,0.0001415907,0.00002343,0.00004125294,0.00005385481,0.00006929063,0.00001589109,0.0002874979],"genre_scores_gemma":[0.9988105,0.0004019854,0.0002323764,0.00003823513,0.00005658573,0.0000458205,0.00008951486,0.000007239589,0.0003178411],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001723986,"threshold_uncertainty_score":0.005767286,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4409504657","doi":"10.1002/cpdd.1534","title":"A Phase 1C, Open Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DM199 Administered Intravenously with a Polyvinyl Chloride Bag in Adult Healthy Subjects and Adults Recently Taking Angiotensin‐Converting Enzyme Inhibitors","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Tolerability; Medicine; Pharmacokinetics; Adverse effect; Dosing; Context (archaeology); Anesthesia; Pharmacology; Internal medicine","authors":[{"name":"Michael Giuffre","is_ca":true},{"name":"Annette Lista","is_ca":false},{"name":"Nick B. Paulson","is_ca":false},{"name":"Lorianne K. Masuoka","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06909627066100327,"gpt":0.4269343132692811,"spread":0.3578380426082778,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009307842,0.001003889,0.001314422,0.000317804,0.0003633687,0.0004562254,0.0004649486,0.0008224314,0.002017763],"category_scores_gemma":[0.0007781016,0.0004141759,0.000535935,0.0002155452,0.00054313,0.0005771333,0.0001874529,0.001552144,0.0003886955],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003613853,"about_ca_system_score_gemma":0.0007277989,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005401418,"about_ca_topic_score_gemma":0.001266525,"domain_scores_codex":[0.9996977,0.0001353823,0.00001836912,0.00005739258,0.00004929765,0.00004185709],"domain_scores_gemma":[0.9995338,0.0001073415,0.0001108153,0.00003924104,0.00004372247,0.0001651209],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5940256,0.1471613,0.007715398,0.0007042124,0.0009903762,0.0003903317,0.0003836712,0.0009707535,0.1592505,0.0002300641,0.001551117,0.08662672],"study_design_scores_gemma":[0.1553496,0.822594,0.01372631,0.00001147843,0.0002262173,0.0001715285,0.00004296907,0.0006225861,0.005838337,0.00006987998,0.001325918,0.00002107058],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965267,0.0005640771,0.0006466988,0.00009086326,0.00003433927,0.001331339,0.0002729377,0.00002971246,0.0005034263],"genre_scores_gemma":[0.992778,0.0008804533,0.001849282,0.00047378,0.0001261815,0.001641606,0.000575572,0.00001408674,0.001661072],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002017763,"threshold_uncertainty_score":0.006750107,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4409956934","doi":"10.1002/cpdd.1538","title":"A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High‐Concentration, Long‐Acting Cabotegravir Formulation in Adults Without HIV","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"GlaxoSmithKline (Canada)","funders":"ViiV Healthcare","keywords":"Medicine; Tolerability; Dosing; Pharmacokinetics; Adverse effect; Pharmacology; Regimen; Internal medicine","authors":[{"name":"Kelong Han","is_ca":false},{"name":"Paul Benn","is_ca":false},{"name":"Jörg Sievers","is_ca":false},{"name":"David Dorey","is_ca":true},{"name":"Michael Warwick‐Sanders","is_ca":false},{"name":"Randa Hareedy","is_ca":false},{"name":"Louise M. Harkness","is_ca":false},{"name":"Claudia Leemereise","is_ca":false},{"name":"Kjersten Offenbecker","is_ca":false},{"name":"Christina Donatti","is_ca":false},{"name":"Darin Brimhall","is_ca":false},{"name":"Christian Schwabe","is_ca":false},{"name":"Craig Boyle","is_ca":false},{"name":"Michael Hassman","is_ca":false},{"name":"Ronald D’Amico","is_ca":false},{"name":"William Spreen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0388030569631078,"gpt":0.4428926940845356,"spread":0.4040896371214278,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002341924,0.00150551,0.002075747,0.0003051551,0.0004558825,0.0008219206,0.0007911726,0.001451512,0.00560956],"category_scores_gemma":[0.002523375,0.0008583185,0.001078485,0.0003538867,0.0009167394,0.0009659777,0.0003235281,0.00228291,0.0007189377],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006946437,"about_ca_system_score_gemma":0.001798753,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007019071,"about_ca_topic_score_gemma":0.002016201,"domain_scores_codex":[0.9991352,0.0004969563,0.00004183781,0.0001582287,0.00007406285,0.00009376065],"domain_scores_gemma":[0.9986746,0.0004608831,0.0003113644,0.0001038675,0.0001162187,0.0003331462],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9571148,0.02253399,0.000942263,0.0004212353,0.0005811101,0.00005343845,0.00006699636,0.000338323,0.005290571,0.0001009631,0.0007977017,0.01175861],"study_design_scores_gemma":[0.7964044,0.1989731,0.002011547,0.00002223454,0.0003648726,0.00004791483,0.00002369758,0.0005912411,0.0006332565,0.0001343382,0.0007781964,0.00001523511],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837399,0.001773762,0.001200252,0.0003276822,0.0002844483,0.009929835,0.001190002,0.0001007276,0.001453366],"genre_scores_gemma":[0.9789257,0.001705302,0.003186467,0.0009567162,0.0002994389,0.01094029,0.001225028,0.00003932934,0.002721686],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00560956,"threshold_uncertainty_score":0.01876587,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2531615040","doi":"10.1002/cpdd.319","title":"Comparison of the Pharmacokinetics of Ketorolac Tromethamine After Continuous Subcutaneous Infusion and Repeat Intramuscular Bolus Injections in Healthy Adult Subjects","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Medicine; Ketorolac Tromethamine; Pharmacokinetics; Anesthesia; Bolus (digestion); Cmax; Crossover study; Intramuscular injection; Ketorolac; Bioavailability; Regimen; Analgesic; Pharmacology; Surgery; Placebo","authors":[{"name":"Michael D. Burdick","is_ca":false},{"name":"Richard D. Mamelok","is_ca":false},{"name":"Michele Hurliman","is_ca":false},{"name":"Mariève Dupuis","is_ca":true},{"name":"Yuli Xie","is_ca":false},{"name":"Julie Grenier","is_ca":true},{"name":"Curtis Sheldon","is_ca":false},{"name":"Michael Gartner","is_ca":false},{"name":"Peter D. Noymer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01752693990052712,"gpt":0.3565817520965321,"spread":0.339054812196005,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006723717,0.0004162171,0.0008142929,0.0002119545,0.0001910019,0.0003330945,0.0001514792,0.0004933627,0.001052371],"category_scores_gemma":[0.001587302,0.0003163856,0.0002201111,0.0001823803,0.0003021501,0.0003042348,0.0000948597,0.0004358435,0.000330803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001758509,"about_ca_system_score_gemma":0.0002175517,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006937542,"about_ca_topic_score_gemma":0.0005222592,"domain_scores_codex":[0.9996333,0.0001272809,0.00002737378,0.00008591904,0.00008380412,0.00004223878],"domain_scores_gemma":[0.9992405,0.000210862,0.0002175667,0.00005778352,0.00008710925,0.0001862829],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5054813,0.01509682,0.1358619,0.0004136264,0.0006745466,0.0007111089,0.001074404,0.0008795669,0.2544507,0.00009698146,0.0006139872,0.08464513],"study_design_scores_gemma":[0.01371031,0.3831296,0.5790662,0.00001876452,0.000510824,0.0009344129,0.0002326721,0.003225198,0.01823358,0.00004869459,0.0008338484,0.00005591143],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991648,0.0002933455,0.0002384382,0.000006903341,0.000007883787,0.00007689099,0.00006964319,0.00001415202,0.0001279491],"genre_scores_gemma":[0.9987105,0.0001551072,0.0005055152,0.0000390183,0.00002529604,0.0001058352,0.0001479963,0.000005339172,0.0003055305],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001052371,"threshold_uncertainty_score":0.003555894,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2761677898","doi":"10.1002/cpdd.394","title":"Categorization of Abuse Potential–Related Adverse Events","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Categorization; Adverse effect; Medical emergency; Pharmacology; Artificial intelligence","authors":[{"name":"Edward M. Sellers","is_ca":true},{"name":"Myroslava K. Romach","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1322844439839624,"gpt":0.5026786822963262,"spread":0.3703942383123637,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006369513,0.000672563,0.001005094,0.007816344,0.0008114011,0.001175415,0.001017358,0.0006177786,0.003038819],"category_scores_gemma":[0.01443565,0.0001564068,0.001282631,0.003034035,0.0004794722,0.0009703388,0.001291477,0.0008085469,0.000722045],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009140443,"about_ca_system_score_gemma":0.002153675,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002539148,"about_ca_topic_score_gemma":0.003153119,"domain_scores_codex":[0.991823,0.001968438,0.002809468,0.0003619548,0.00267685,0.0003603238],"domain_scores_gemma":[0.9842455,0.004009128,0.004045468,0.001033291,0.006210663,0.0004560117],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.002881922,0.0007430016,0.536884,0.005865731,0.000589082,0.004717265,0.002778313,0.003563124,0.02527222,0.005838963,0.01534299,0.3955233],"study_design_scores_gemma":[0.0002558334,0.002779903,0.8526664,0.002110005,0.0006348889,0.01336907,0.003278041,0.0145663,0.01514199,0.01183057,0.08309729,0.0002697214],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7995834,0.01816676,0.08096488,0.002666626,0.0007482588,0.02063377,0.0186707,0.001236893,0.05732864],"genre_scores_gemma":[0.8164594,0.005774163,0.1527565,0.001229733,0.000265005,0.003451582,0.01523204,0.0001496851,0.004681889],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007816344,"threshold_uncertainty_score":0.03368562,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2953947897","doi":"10.1002/cpdd.720","title":"A First‐in‐Human Phase 1 Randomized Single and Multiple Ascending Dose Study of RPh201 in Healthy Volunteers","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Medicinal Plants and Neuroprotection","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Dosing; Placebo; Randomized controlled trial; Erythema; Single Center; Anesthesia; Internal medicine; Surgery; Pathology","authors":[{"name":"Zadik Hazan","is_ca":false},{"name":"Konstantin Adamsky","is_ca":false},{"name":"Andre Lucassen","is_ca":false},{"name":"Leonard A. Levin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06716203326062947,"gpt":0.4218195771529872,"spread":0.3546575438923578,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002247592,0.00234813,0.003569461,0.0005880279,0.00104759,0.0008870943,0.0008081206,0.002055232,0.007005855],"category_scores_gemma":[0.001474667,0.001295741,0.001293905,0.0003633446,0.001377532,0.001241877,0.000457363,0.002389169,0.001372834],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005069335,"about_ca_system_score_gemma":0.001759475,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006538013,"about_ca_topic_score_gemma":0.00206854,"domain_scores_codex":[0.9993037,0.0002794798,0.00004642643,0.0001515371,0.00007365578,0.0001451574],"domain_scores_gemma":[0.9991428,0.0001907887,0.0001508417,0.0001157651,0.0001122488,0.0002877255],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8886806,0.06928272,0.001022969,0.0006050927,0.00053642,0.0001181746,0.0001587996,0.0002950902,0.01850091,0.0001508374,0.001468984,0.01917948],"study_design_scores_gemma":[0.5022486,0.4916534,0.002622601,0.00001536316,0.0002639882,0.00004286473,0.00003601104,0.0002333908,0.001282864,0.0001685198,0.001406794,0.00002561981],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9642772,0.002292437,0.002594943,0.0006023258,0.0005412012,0.02537158,0.001740312,0.0002082415,0.002371765],"genre_scores_gemma":[0.951628,0.002464871,0.006666614,0.002412053,0.0008500001,0.02433487,0.001320886,0.00006378291,0.01025895],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007005855,"threshold_uncertainty_score":0.02343684,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3017244061","doi":"10.1002/cpdd.788","title":"Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine (a CYP1A2 Substrate) in Patients With <i>BRAF</i><sup>V600</sup> Mutation–Positive Malignancies","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Pharmacokinetics; Vemurafenib; Pharmacology; Mutation; Oncology; Internal medicine; Cancer research; Genetics; Cancer; Gene","authors":[{"name":"Weijiang Zhang","is_ca":false},{"name":"Christine McIntyre","is_ca":false},{"name":"Todd Riehl","is_ca":false},{"name":"Harper Forbes","is_ca":true},{"name":"Enric Bertran","is_ca":false},{"name":"Hye Jin Choi","is_ca":false},{"name":"Dae Ho Lee","is_ca":false},{"name":"Jeeyun Lee","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01806922812262594,"gpt":0.2851740033891128,"spread":0.2671047752664868,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001188997,0.0006086488,0.001306321,0.0001733637,0.0001833748,0.0005070816,0.0002956238,0.000441695,0.0006648109],"category_scores_gemma":[0.001786025,0.0003744988,0.001105206,0.0001877537,0.0003973718,0.0005154914,0.0001755541,0.0014069,0.000112856],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005657311,"about_ca_system_score_gemma":0.0005318421,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004321228,"about_ca_topic_score_gemma":0.0007350056,"domain_scores_codex":[0.9993851,0.0003398529,0.00003139401,0.0001035889,0.00006832654,0.00007156389],"domain_scores_gemma":[0.9990163,0.000361269,0.00030753,0.00008014636,0.00003822375,0.0001965734],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.663625,0.01871086,0.03634991,0.0003001149,0.002689895,0.0002747547,0.0002560306,0.009564163,0.1175892,0.0001440791,0.0008927703,0.1496033],"study_design_scores_gemma":[0.08254845,0.7430032,0.1340164,0.00002519327,0.001326345,0.0006120664,0.00009320005,0.01213379,0.02429578,0.0001933311,0.001680521,0.00007165153],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992199,0.0003963559,0.0001585703,0.00003345275,0.00001322652,0.00003271543,0.00003858001,0.00001105858,0.00009612765],"genre_scores_gemma":[0.999374,0.0001223896,0.0002731246,0.00003296126,0.00002164301,0.00003615621,0.00005409092,0.000003682514,0.00008190543],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001306321,"threshold_uncertainty_score":0.006288052,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2793645751","doi":"10.1002/cpdd.433","title":"Pharmacokinetic Drug Interaction Study of Bazedoxifene and Ibuprofen","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"Pfizer","keywords":"Pharmacokinetics; Ibuprofen; Medicine; Bioequivalence; Crossover study; Pharmacology; Confidence interval; Internal medicine; Urology; Placebo; Pathology","authors":[{"name":"William McKeand","is_ca":false},{"name":"Susan Baird‐Bellaire","is_ca":false},{"name":"James Ermer","is_ca":true},{"name":"Alain Patat","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02197730178811429,"gpt":0.3875958379826537,"spread":0.3656185361945394,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001339575,0.0004020672,0.001482446,0.0003627325,0.0002982279,0.0005076269,0.0002230435,0.0006094684,0.002113854],"category_scores_gemma":[0.003778133,0.0003197802,0.0008805266,0.0003253446,0.0002815878,0.0003104151,0.0002088122,0.0006772943,0.0002809565],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003829747,"about_ca_system_score_gemma":0.0004996703,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001289187,"about_ca_topic_score_gemma":0.0008000905,"domain_scores_codex":[0.998643,0.0007776426,0.00005665414,0.0001220311,0.0003246715,0.00007609027],"domain_scores_gemma":[0.9987937,0.0006044779,0.0002746461,0.00007013077,0.0001019614,0.0001550869],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3437408,0.01397194,0.1132274,0.001051345,0.007152005,0.001679221,0.000662911,0.003009967,0.4191082,0.0005119533,0.0008628059,0.09502138],"study_design_scores_gemma":[0.03531351,0.401281,0.3453334,0.00006704066,0.008877855,0.006271959,0.0004439029,0.02496563,0.1627377,0.0006442724,0.0139023,0.000161502],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962615,0.00189515,0.001135794,0.00006757261,0.00003558939,0.0001410323,0.00008360903,0.0000222104,0.0003574806],"genre_scores_gemma":[0.9980502,0.0004608201,0.0007453199,0.00006808258,0.00004392897,0.00006582549,0.000101547,0.00000592691,0.0004583499],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002113854,"threshold_uncertainty_score":0.007084429,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2141030907","doi":"10.1002/cpdd.48","title":"Differential Pharmacokinetics of Ganitumab in Patients With Metastatic Pancreatic Cancer Versus Other Advanced Solid Cancers","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Quebec Rehabilitation Research Network","funders":"","keywords":"Gemcitabine; Medicine; Pancreatic cancer; Pharmacokinetics; Oncology; Internal medicine; Volume of distribution; Response Evaluation Criteria in Solid Tumors; Cancer; Clinical trial; Pharmacology; Phases of clinical research","authors":[{"name":"Min Zhu","is_ca":false},{"name":"Nathalie Gosselin","is_ca":true},{"name":"Mita Kuchimanchi","is_ca":false},{"name":"Jessica Johnson","is_ca":false},{"name":"Ian McCaffery","is_ca":false},{"name":"Samer Mouksassi","is_ca":true},{"name":"Elwyn Loh","is_ca":false},{"name":"Jianfeng Lü","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05145983826760502,"gpt":0.429606022472052,"spread":0.378146184204447,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008005854,0.0001835482,0.000911316,0.0002144847,0.0001356065,0.0005776687,0.000109434,0.000217317,0.0005999094],"category_scores_gemma":[0.003259404,0.0001469698,0.0003783024,0.0003882587,0.0002467894,0.0004388164,0.00021382,0.0005050966,0.000120553],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005849035,"about_ca_system_score_gemma":0.0003528274,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007058441,"about_ca_topic_score_gemma":0.0009754354,"domain_scores_codex":[0.999626,0.000192307,0.00002711346,0.00006777018,0.00005531821,0.00003143114],"domain_scores_gemma":[0.9990103,0.0005320846,0.0002608885,0.0000520131,0.00003916465,0.0001054845],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0691212,0.0009237031,0.7412194,0.0003018946,0.000921939,0.001987231,0.000628557,0.01284576,0.07152315,0.0004704017,0.0009286335,0.09912808],"study_design_scores_gemma":[0.001178381,0.01851084,0.9405717,0.00002194743,0.0004153872,0.003769298,0.0001566998,0.02078053,0.01127784,0.000533923,0.002742304,0.00004110887],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983554,0.0007260613,0.0003801268,0.00004670592,0.000004059961,0.00001462344,0.00009698129,0.00001492247,0.000361069],"genre_scores_gemma":[0.9992918,0.0001796145,0.0002351824,0.00003500271,0.0000062527,0.000008266255,0.000143951,0.000005002766,0.00009494247],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.000911316,"threshold_uncertainty_score":0.004243791,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2800574556","doi":"10.1002/cpdd.458","title":"A Study of the Potential Interaction Between Bazedoxifene and Atorvastatin in Healthy Postmenopausal Women","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"Pfizer","keywords":"Atorvastatin; Cmax; Medicine; Pharmacokinetics; Pharmacology; Dosing; Urology; Internal medicine","authors":[{"name":"William McKeand","is_ca":false},{"name":"Susan Baird‐Bellaire","is_ca":true},{"name":"James Ermer","is_ca":false},{"name":"Alain Patat","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04281427300583475,"gpt":0.4065403169503107,"spread":0.363726043944476,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001475186,0.0005224533,0.001111992,0.0002528276,0.0004772814,0.0003575379,0.0002283592,0.0007121565,0.001092042],"category_scores_gemma":[0.001707911,0.0004614875,0.0006837362,0.0002578638,0.0003574873,0.0002734105,0.0001882783,0.0004965426,0.0001836022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002786073,"about_ca_system_score_gemma":0.0004860369,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001289229,"about_ca_topic_score_gemma":0.001925625,"domain_scores_codex":[0.9993768,0.000324098,0.00003128513,0.00008314766,0.0001317036,0.00005300289],"domain_scores_gemma":[0.9993533,0.000272406,0.0001417715,0.00004603164,0.00004542581,0.0001410268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5120115,0.01394783,0.2394093,0.0008930817,0.002878694,0.0009972228,0.0007721249,0.0006285032,0.1779537,0.000126442,0.0003174847,0.05006421],"study_design_scores_gemma":[0.01952164,0.3506005,0.6100255,0.00002280359,0.002348818,0.0009919283,0.0002709341,0.001677787,0.01202747,0.0001296116,0.002326715,0.00005627368],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987119,0.0008516169,0.0001653304,0.00002022646,0.000009242225,0.00006559888,0.00004877378,0.000003919691,0.0001233953],"genre_scores_gemma":[0.9987366,0.0003831603,0.0003397514,0.0000560546,0.00003364038,0.0000887199,0.00008579066,0.000002339405,0.0002739848],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001475186,"threshold_uncertainty_score":0.007801592,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4318332812","doi":"10.1002/cpdd.1210","title":"A Randomized, Double‐Blind, Parallel Design Thorough QT Study With a Nested Crossover to Compare the Cardiac Safety of Amiselimod With Placebo and Positive Control in Healthy Volunteers","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Salix Pharmaceuticals; Bausch Health; Mitsubishi Tanabe Pharma Corporation","keywords":"Medicine; Placebo; Moxifloxacin; Crossover study; Dosing; QT interval; Anesthesia; Pharmacokinetics; Adverse effect; Confidence interval; Oral administration; Internal medicine; Antibiotics","authors":[{"name":"Jimin Lee","is_ca":false},{"name":"Robert Lester","is_ca":false},{"name":"Terry O’Reilly","is_ca":false},{"name":"Ezra R. Lowe","is_ca":false},{"name":"Neal E. Slatkin","is_ca":false},{"name":"Howard Franklin","is_ca":false},{"name":"Robert J. Israel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03947145882336801,"gpt":0.366629509452682,"spread":0.327158050629314,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005608177,0.001834593,0.005508388,0.00070333,0.001151363,0.0009849966,0.001485663,0.002559796,0.003781825],"category_scores_gemma":[0.003990982,0.001797082,0.002095995,0.000523149,0.002445503,0.001079928,0.0007053454,0.002497759,0.0008606165],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007447774,"about_ca_system_score_gemma":0.002378479,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009074524,"about_ca_topic_score_gemma":0.001528512,"domain_scores_codex":[0.996838,0.001474768,0.0002554893,0.0006964928,0.0003944605,0.000340806],"domain_scores_gemma":[0.996824,0.0008163371,0.0006131928,0.0005718567,0.0003650419,0.0008096198],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9478711,0.03385285,0.0005414805,0.0002863035,0.0004985237,0.00003023914,0.00009182235,0.000257434,0.01032213,0.0001499081,0.0002924876,0.005805735],"study_design_scores_gemma":[0.7171743,0.2792147,0.001505193,0.000009791363,0.0002684681,0.00002166987,0.00001453024,0.0003194301,0.0008766445,0.0001195514,0.0004545198,0.0000212097],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9726926,0.0008389868,0.003235507,0.0002416444,0.0007286488,0.02054978,0.000642486,0.0001462897,0.0009240687],"genre_scores_gemma":[0.934795,0.0008985912,0.01746867,0.00125249,0.001020161,0.03942978,0.0008221139,0.00005472458,0.00425841],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005608177,"threshold_uncertainty_score":0.02965921,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2123762312","doi":"10.1002/cpdd.35","title":"Pharmacokinetics of Irinotecan With and Without Panitumumab Coadministration in Patients With Metastatic Colorectal Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"Pfizer; Amgen","keywords":"Medicine; Panitumumab; Irinotecan; Pharmacokinetics; Colorectal cancer; Oncology; Pharmacology; Internal medicine; Cancer; Cetuximab","authors":[{"name":"Bingbing Yang","is_ca":false},{"name":"Chi‐Yuan Wu","is_ca":false},{"name":"Eric X. Chen","is_ca":true},{"name":"Jeffrey R. Infante","is_ca":false},{"name":"Alin Chen","is_ca":false},{"name":"Bing Gao","is_ca":false},{"name":"Brian P. Smith","is_ca":false},{"name":"Jason B. Litten","is_ca":false},{"name":"Hagen F. Kennecke","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0298835490165456,"gpt":0.3673054002709479,"spread":0.3374218512544023,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000668861,0.0003468784,0.001281879,0.0002241362,0.0002431443,0.0004939024,0.0001971809,0.0003054407,0.0006589784],"category_scores_gemma":[0.001662908,0.0003035106,0.0003828382,0.0003775884,0.0003203524,0.0005834336,0.0001787643,0.001020719,0.0001606415],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007812492,"about_ca_system_score_gemma":0.0007704763,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006898936,"about_ca_topic_score_gemma":0.002111553,"domain_scores_codex":[0.9994403,0.000252904,0.00002866312,0.0001087113,0.0001144173,0.00005502152],"domain_scores_gemma":[0.9994504,0.0001368595,0.0001966424,0.0000348646,0.00003121489,0.0001500921],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2912704,0.01220909,0.1425191,0.0006726598,0.002968756,0.001730853,0.0007883777,0.00798707,0.180672,0.0003118964,0.001999053,0.3568707],"study_design_scores_gemma":[0.03130577,0.4485125,0.4559142,0.00005749707,0.001801709,0.005104638,0.0002663007,0.01075224,0.03564757,0.0002532454,0.01029661,0.00008771655],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972091,0.001878974,0.0002546414,0.00006037635,0.000017881,0.00007016696,0.00005536537,0.00002020658,0.0004332603],"genre_scores_gemma":[0.9984879,0.0005631364,0.0004465548,0.00006094245,0.00003740881,0.00003661735,0.000128283,0.00000688072,0.0002322395],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001281879,"threshold_uncertainty_score":0.005668402,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4384126864","doi":"10.1002/cpdd.1300","title":"Comparative Bioavailability of Two Daily Subcutaneous Doses Versus a Single Dose of Intramuscular and Vaginal Progesterone Formulations in Healthy Postmenopausal Females","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Ovarian function and disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bioavailability; Luteal phase; Crossover study; Pharmacokinetics; Estrous cycle; Internal medicine; Hormone; Pharmacology","authors":[{"name":"Mario Tanguay","is_ca":true},{"name":"Barbara Cometti","is_ca":false},{"name":"Sylvie Boudreault","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1382611868117648,"gpt":0.443334695507818,"spread":0.3050735086960531,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001188474,0.0004078073,0.001004513,0.0003145531,0.0002519104,0.0002702227,0.0001982719,0.0005104129,0.001281818],"category_scores_gemma":[0.001666573,0.0003321439,0.0004746112,0.0001678141,0.0004247245,0.0003311179,0.0001583074,0.0006424795,0.0002320025],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002115289,"about_ca_system_score_gemma":0.0002707767,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005701921,"about_ca_topic_score_gemma":0.00043082,"domain_scores_codex":[0.9995085,0.0002293573,0.00002768344,0.00009454558,0.00009119932,0.00004877471],"domain_scores_gemma":[0.9992141,0.0003288012,0.0001896898,0.0000676789,0.00006312712,0.0001366756],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.705853,0.0195455,0.02006533,0.0003658379,0.0004380799,0.000245605,0.000477663,0.0007718679,0.1995719,0.00009253369,0.0003479064,0.05222479],"study_design_scores_gemma":[0.02575746,0.8669224,0.08227178,0.00001454332,0.0004055843,0.0002358074,0.0001640439,0.001901024,0.02150717,0.00006941286,0.0007198153,0.0000309011],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994621,0.000227574,0.0001097635,0.00001476763,0.00001079508,0.00004674753,0.00003572903,0.000006287937,0.00008626917],"genre_scores_gemma":[0.9989014,0.0001608606,0.0003931086,0.00003864642,0.00004324263,0.00009225296,0.00006322465,0.00000381857,0.0003035484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001281818,"threshold_uncertainty_score":0.00628531,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3038254578","doi":"10.1002/cpdd.822","title":"Effect of Itraconazole, a Potent CYP3A4 Inhibitor, on the Steady‐State Pharmacokinetics of Vemurafenib in Patients With <i>BRAF</i><sup>V600</sup> Mutation–Positive Malignancies","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"","keywords":"Vemurafenib; Itraconazole; Medicine; Pharmacokinetics; Dosing; Pharmacology; Crossover study; Confidence interval; Area under the curve; Internal medicine; Adverse effect; Urology; Gastroenterology; Cancer; Dermatology; Pathology; Metastatic melanoma","authors":[{"name":"Weijiang Zhang","is_ca":false},{"name":"Michael S. Mathisen","is_ca":false},{"name":"Grant R. Goodman","is_ca":false},{"name":"Harper Forbes","is_ca":true},{"name":"Yuyao Song","is_ca":true},{"name":"Enric Bertran","is_ca":false},{"name":"Lev Demidov","is_ca":false},{"name":"Sang Joon Shin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01222371963840386,"gpt":0.2778418450221536,"spread":0.2656181253837497,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000573252,0.0002694067,0.0006497716,0.0001345719,0.0001281807,0.0003238191,0.0001270545,0.0002396828,0.0008935453],"category_scores_gemma":[0.001323658,0.0002061332,0.0005806236,0.0002004168,0.0001976445,0.0003543058,0.0001487873,0.0007994598,0.0001310753],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003669882,"about_ca_system_score_gemma":0.0003931908,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000555387,"about_ca_topic_score_gemma":0.001198262,"domain_scores_codex":[0.9996628,0.0001422629,0.00002404908,0.00005873452,0.00004388469,0.00006830043],"domain_scores_gemma":[0.9993755,0.0002337098,0.0001484211,0.00004697666,0.00003246474,0.0001628621],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.3003532,0.01709053,0.09210833,0.0002558295,0.00200324,0.000886168,0.000458847,0.01056035,0.2882102,0.0002235751,0.001780956,0.2860688],"study_design_scores_gemma":[0.01203234,0.3327371,0.5794472,0.00002452756,0.001308536,0.001317876,0.0001295042,0.01351045,0.0560087,0.0001848085,0.003213498,0.0000854319],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992187,0.0002701492,0.0001062323,0.00003366413,0.000009181433,0.00001738605,0.00004206845,0.00001094415,0.0002916784],"genre_scores_gemma":[0.999413,0.00009329964,0.0001467149,0.0000255985,0.00001535742,0.00001810171,0.00008158744,0.000002592351,0.0002037778],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008935453,"threshold_uncertainty_score":0.003031671,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3119947423","doi":"10.1002/cpdd.901","title":"A Colon‐Targeted Adsorbent (DAV132) Does Not Affect the Pharmacokinetics of Warfarin or Clonazepam in Healthy Subjects","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Warfarin; Bioequivalence; Pharmacokinetics; Clonazepam; Crossover study; Pharmacology; Cmax; Concomitant; Pharmacodynamics; Drug; Internal medicine; Placebo","authors":[{"name":"Jean‐Louis Pinquier","is_ca":false},{"name":"Marina Varastet","is_ca":false},{"name":"D. E.R. Meyers","is_ca":false},{"name":"Sakina Sayah‐Jeanne","is_ca":false},{"name":"Céline Féger","is_ca":true},{"name":"Olivia Gaumétou","is_ca":false},{"name":"Tanguy Corbel","is_ca":false},{"name":"Jean de Gunzburg","is_ca":false},{"name":"France Mentré","is_ca":false},{"name":"Annie Ducher","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1668108786195618,"gpt":0.497394297777827,"spread":0.3305834191582652,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001019611,0.0005462845,0.001009732,0.0001679174,0.0003248122,0.0003446072,0.0001953825,0.0008938445,0.001808711],"category_scores_gemma":[0.0014477,0.0003224021,0.0005137043,0.000170327,0.0005920607,0.0003734343,0.0001721755,0.0005457719,0.0003179408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002503053,"about_ca_system_score_gemma":0.0003421639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001169995,"about_ca_topic_score_gemma":0.001190094,"domain_scores_codex":[0.9992163,0.00037193,0.00004838792,0.0001694197,0.000114683,0.00007921158],"domain_scores_gemma":[0.9994479,0.0001523078,0.0001540855,0.00007507165,0.00004551858,0.000125113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7492338,0.01375313,0.02887851,0.0004074766,0.001134714,0.0002844903,0.0003373317,0.0004139836,0.1657127,0.0001239547,0.0009706301,0.03874918],"study_design_scores_gemma":[0.04823836,0.7223735,0.1996606,0.00003129224,0.001259456,0.0005948122,0.0001810033,0.001628385,0.0224599,0.0001460418,0.003367141,0.00005964979],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989402,0.0003635385,0.0001849488,0.00002874413,0.00002837816,0.00008591566,0.0001157188,0.0000151097,0.000237494],"genre_scores_gemma":[0.9990308,0.0001105103,0.0002248692,0.00007889879,0.00003366653,0.00005837951,0.0001109273,0.00000457982,0.0003473228],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001808711,"threshold_uncertainty_score":0.006050706,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1904376711","doi":"10.1002/cpdd.27","title":"Impact of Tesamorelin, a Growth Hormone‐Releasing Factor (GRF) Analogue, on the Pharmacokinetics of Simvastatin and Ritonavir in Healthy Volunteers","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Theratechnologies (Canada)","funders":"","keywords":"Ritonavir; Simvastatin; Cmax; Medicine; Pharmacokinetics; Pharmacology; CYP3A; Crossover study; Regimen; Dosing; Internal medicine; Immunology; Placebo; Human immunodeficiency virus (HIV)","authors":[{"name":"Shirley Teng","is_ca":false},{"name":"Diane Potvin","is_ca":true},{"name":"Jean‐Claude Mamputu","is_ca":true},{"name":"Geneviève Vincent","is_ca":true},{"name":"Monika Zoltowska","is_ca":true},{"name":"Josée Morin","is_ca":true},{"name":"Saida Hatimi","is_ca":true},{"name":"Sophie‐Élise Michaud","is_ca":true},{"name":"Kim A. High","is_ca":true},{"name":"Murray P. Ducharme","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04274883741436251,"gpt":0.3949269658680695,"spread":0.3521781284537069,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00119551,0.0003632423,0.0007470388,0.0001420735,0.0002135792,0.0003868205,0.000137932,0.0005052899,0.0009484749],"category_scores_gemma":[0.001641576,0.0002741552,0.0004730289,0.0001387762,0.0003802351,0.0002607054,0.0001542132,0.0003878057,0.0002267353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001738316,"about_ca_system_score_gemma":0.0002435032,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005692561,"about_ca_topic_score_gemma":0.0006480773,"domain_scores_codex":[0.9991903,0.0004766692,0.0000518501,0.000132946,0.00009251473,0.00005575339],"domain_scores_gemma":[0.9995157,0.0002092901,0.00008991767,0.00005378649,0.00003501937,0.00009627925],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5799965,0.008121439,0.06716172,0.0004102066,0.001088638,0.0006933851,0.0006340141,0.001261642,0.2455188,0.0001518163,0.0004867898,0.09447498],"study_design_scores_gemma":[0.02312188,0.5062706,0.4076557,0.00002315054,0.001287016,0.001621937,0.0002684728,0.003992743,0.05241422,0.0003075371,0.002963834,0.00007281554],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987601,0.0005462666,0.0001731839,0.00002801341,0.00001249129,0.00005467802,0.00008441909,0.00001190142,0.0003287913],"genre_scores_gemma":[0.9991316,0.0001596847,0.0003300524,0.00004888585,0.00001569915,0.00003352523,0.00008064512,0.000003626233,0.00019627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00119551,"threshold_uncertainty_score":0.006322503,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4409765779","doi":"10.1002/cpdd.1540","title":"Clinical Evaluation of Potential Interaction Between Bemnifosbuvir and Ruzasvir With an Assessment of Food Effect: Results of a Phase 1 Study in Healthy Participants","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Altasciences (Canada)","funders":"","keywords":"NS5A; Medicine; Pharmacology; Drug; Adverse effect; Hepatitis C virus; NS5B; Combination therapy; Chronic hepatitis; Hepacivirus; Virus; Virology","authors":[{"name":"Xiao‐Jian Zhou","is_ca":false},{"name":"Gaetano Morelli","is_ca":true},{"name":"Maureen Montrond","is_ca":false},{"name":"Shannan Lynch","is_ca":false},{"name":"Keith Pietropaolo","is_ca":false},{"name":"Bruce Belanger","is_ca":false},{"name":"Arantxa Horga","is_ca":false},{"name":"Janet Hammond","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.217051315865395,"gpt":0.6195449109795277,"spread":0.4024935951141327,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003554554,0.001451033,0.002085975,0.0002945103,0.0004994958,0.0004847363,0.0005584398,0.001549963,0.001773258],"category_scores_gemma":[0.002562559,0.0005665408,0.001356028,0.000297301,0.0005927794,0.0006920989,0.0003498678,0.00155213,0.0004873438],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004074824,"about_ca_system_score_gemma":0.0006366859,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005938338,"about_ca_topic_score_gemma":0.0008945969,"domain_scores_codex":[0.9982727,0.0009757163,0.0000729282,0.0002776501,0.000253185,0.0001477498],"domain_scores_gemma":[0.9984462,0.0003795788,0.00031114,0.0001087812,0.0002163699,0.0005379854],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6466389,0.08613229,0.04092906,0.0008172187,0.002876229,0.0008038969,0.0006377648,0.001400761,0.1407885,0.00007714154,0.0008147674,0.07808352],"study_design_scores_gemma":[0.03507235,0.8885801,0.06100277,0.00001489192,0.001199118,0.000511214,0.000106667,0.001232282,0.01070414,0.00005389304,0.001474843,0.00004772956],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976348,0.0007827794,0.0003661455,0.00005638964,0.0000305118,0.0005756901,0.0002415597,0.00002333778,0.0002887514],"genre_scores_gemma":[0.996106,0.0005340459,0.001097203,0.0001943025,0.00007341938,0.0006140714,0.0005342143,0.00001568897,0.0008310874],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003554554,"threshold_uncertainty_score":0.01879847,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3095574760","doi":"10.1002/cpdd.884","title":"Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed‐Dose Combination Tablets to Canadian‐Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Metformin; Bioequivalence; Medicine; Crossover study; Pharmacology; Type 2 diabetes; Pharmacokinetics; Confidence interval; Diabetes mellitus; Internal medicine; Endocrinology; Placebo","authors":[{"name":"Vikas Kumar Dawra","is_ca":false},{"name":"Kathleen Pelletier","is_ca":false},{"name":"Kyle Matschke","is_ca":false},{"name":"Haihong Shi","is_ca":false},{"name":"Anne Hickman","is_ca":false},{"name":"Susan Zhou","is_ca":false},{"name":"Rajesh Krishna","is_ca":false},{"name":"Vaishali Sahasrabudhe","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05629632715691588,"gpt":0.3513404351448615,"spread":0.2950441079879456,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001779022,0.0003820187,0.0009614125,0.0003877285,0.0002547428,0.0005653538,0.0004283575,0.0005700888,0.0007383173],"category_scores_gemma":[0.002274045,0.0004061153,0.00060501,0.0005500118,0.0005705498,0.0004178325,0.0001934976,0.0008437398,0.0001180321],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001324079,"about_ca_system_score_gemma":0.001524069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01018088,"about_ca_topic_score_gemma":0.01243532,"domain_scores_codex":[0.9981499,0.0008497333,0.00009753233,0.0002897219,0.0004948138,0.0001184279],"domain_scores_gemma":[0.9994523,0.00011317,0.0001794631,0.00006474548,0.000084961,0.0001054136],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.403074,0.008233245,0.008074129,0.0005065984,0.001208159,0.00009543381,0.0005814243,0.002135269,0.5017388,0.0003734721,0.0006102323,0.07336935],"study_design_scores_gemma":[0.04600551,0.5650644,0.1631863,0.00009572073,0.002204206,0.0003681822,0.0002710623,0.01166798,0.2050854,0.0001741821,0.005675341,0.0002017436],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985763,0.0005263529,0.0003591535,0.00001742969,0.00001990132,0.0001343871,0.0001374264,0.00000914253,0.0002199159],"genre_scores_gemma":[0.9974326,0.0003474411,0.001393146,0.00004521989,0.00001499964,0.0001065087,0.0002411864,0.000006076398,0.0004128037],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01018088,"threshold_uncertainty_score":0.02024329,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3172814721","doi":"10.1002/cpdd.953","title":"Effects of Lemborexant on the Pharmacokinetics of Oral Contraceptives: Results From a Phase 1 Drug‐Drug Interaction Study in Healthy Females","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Pharmacokinetics; Medicine; Drug; Tolerability; Pharmacology; Adverse effect; Drug interaction; Internal medicine","authors":[{"name":"Ishani Landry","is_ca":false},{"name":"Jagadeesh Aluri","is_ca":false},{"name":"Nancy Hall","is_ca":false},{"name":"Gleb Filippov","is_ca":false},{"name":"Satish Dayal","is_ca":false},{"name":"Margaret Moline","is_ca":false},{"name":"Larisa Reyderman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1643123047220055,"gpt":0.4857998073438024,"spread":0.3214875026217969,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009712934,0.0006714842,0.0009400469,0.0002712237,0.0003586903,0.000307105,0.0002340624,0.0004573486,0.002465396],"category_scores_gemma":[0.001045016,0.0003426611,0.0007161297,0.0001990671,0.0003761745,0.0003505677,0.0001931872,0.0006449248,0.0003685013],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003404803,"about_ca_system_score_gemma":0.0004442012,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000789149,"about_ca_topic_score_gemma":0.00182404,"domain_scores_codex":[0.999506,0.0002216372,0.00003160814,0.0001072878,0.00008170668,0.00005170401],"domain_scores_gemma":[0.9993154,0.0001742836,0.0002242202,0.00004377976,0.00005137141,0.0001909839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3072668,0.05451046,0.07901414,0.0008949183,0.003929268,0.001306921,0.001088869,0.001808779,0.4192861,0.0001299467,0.002040705,0.1287231],"study_design_scores_gemma":[0.03228991,0.5995291,0.3271967,0.00003397958,0.002130967,0.002114572,0.000216356,0.002247672,0.02888269,0.00009000975,0.005183019,0.00008512886],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986664,0.0005746491,0.0002037193,0.00004299615,0.000009759485,0.0001194139,0.0001616907,0.0000148226,0.0002065014],"genre_scores_gemma":[0.9973524,0.0006328294,0.000635208,0.0001697795,0.00003737022,0.0001176036,0.000344857,0.00001363746,0.0006964198],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002465396,"threshold_uncertainty_score":0.008247554,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2097275353","doi":"10.1002/cpdd.87","title":"Population pharmacokinetic analysis of dutogliptin, a selective dipeptidyl peptidase‐4 inhibitor","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Quebec Rehabilitation Research Network","funders":"","keywords":"Medicine; Dipeptidyl peptidase-4; Dipeptidyl peptidase-4 inhibitor; Pharmacokinetics; Pharmacology; Dipeptidyl peptidase; Population; Diabetes mellitus; Type 2 diabetes; Endocrinology; Biochemistry; Enzyme; Environmental health","authors":[{"name":"Jean‐Francois Marier","is_ca":true},{"name":"Samer Mouksassi","is_ca":true},{"name":"Nathalie Gosselin","is_ca":true},{"name":"Jianke Li","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02371763563722724,"gpt":0.3603088754721077,"spread":0.3365912398348805,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001504241,0.0002864201,0.0006202727,0.0004087343,0.0001231257,0.0004964465,0.0001976323,0.0002474352,0.0004432626],"category_scores_gemma":[0.002230113,0.0001598237,0.0005167275,0.0004243462,0.0001407166,0.0001978904,0.000192839,0.0003963569,0.0001049718],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003959666,"about_ca_system_score_gemma":0.0004862508,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001104437,"about_ca_topic_score_gemma":0.0005829564,"domain_scores_codex":[0.9994451,0.0002769451,0.00002585902,0.0001095985,0.0001142027,0.0000282241],"domain_scores_gemma":[0.9992687,0.0003654973,0.000161904,0.00008779074,0.00007593527,0.00004018568],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03146615,0.00212843,0.6874779,0.0004563443,0.004813638,0.000840076,0.0007375689,0.03849188,0.07496613,0.001020998,0.001787051,0.1558138],"study_design_scores_gemma":[0.001092509,0.02244901,0.8475371,0.00002473349,0.002200122,0.002067653,0.0001795925,0.09142891,0.02619696,0.001349137,0.005352123,0.0001221209],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921995,0.0004601858,0.006040378,0.00002686377,0.000003611226,0.00007842806,0.0007334367,0.00004982981,0.0004077153],"genre_scores_gemma":[0.99568,0.0002600679,0.002470612,0.00004030717,0.000008684518,0.00008612643,0.001216778,0.000009324826,0.0002281502],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001504241,"threshold_uncertainty_score":0.007955313,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069868586","doi":"10.1002/cpdd.196","title":"Population pharmacokinetic modeling of motesanib and its active metabolite, M4, in cancer patients","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Quebec Rehabilitation Research Network","funders":"","keywords":"Medicine; Pharmacokinetics; Dosing; Covariate; Population; Demographics; Metabolite; Active metabolite; Internal medicine; Pharmacology; Oncology; Demography; Statistics; Environmental health","authors":[{"name":"Nathalie Gosselin","is_ca":true},{"name":"Samer Mouksassi","is_ca":true},{"name":"Jianfeng Lü","is_ca":false},{"name":"Cheng‐Pang Hsu","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1516378251483388,"gpt":0.4866974679411927,"spread":0.3350596427928539,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001715162,0.0004031962,0.0008432436,0.0002983834,0.0001405479,0.0007082017,0.0005267386,0.0005117627,0.0008079323],"category_scores_gemma":[0.003175066,0.0003235836,0.001102827,0.000349402,0.0001686618,0.000363006,0.0003595823,0.000634101,0.0002196981],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005166774,"about_ca_system_score_gemma":0.0009103999,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005097721,"about_ca_topic_score_gemma":0.002453991,"domain_scores_codex":[0.9995408,0.0002711512,0.00001731617,0.00008137002,0.00005064334,0.00003880205],"domain_scores_gemma":[0.9991134,0.0005863208,0.0001468309,0.0000463253,0.0000770455,0.00003004514],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.00269447,0.0002906694,0.06255553,0.0001445058,0.001075735,0.0005268214,0.0003034486,0.8890791,0.006475115,0.002432933,0.001371763,0.03304997],"study_design_scores_gemma":[0.0001388384,0.0009014716,0.01690876,0.00001225849,0.0003032194,0.0002624758,0.00004754426,0.9759582,0.001208804,0.002445851,0.001780843,0.00003169759],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8962786,0.0008788824,0.09857796,0.0004953509,0.00001737561,0.000163074,0.00137792,0.0001947299,0.002016031],"genre_scores_gemma":[0.9867801,0.000481757,0.01034249,0.000107502,0.00001511842,0.0002103768,0.0009537939,0.00002847599,0.001080218],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005097721,"threshold_uncertainty_score":0.01013607,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413114117","doi":"10.1002/cpdd.1583","title":"Safety, Tolerability, and Pharmacokinetics of the Long‐Acting SARS‐CoV‐2–Neutralizing Monoclonal Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) in Healthy Chinese Adults","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"AstraZeneca","keywords":"Medicine; Tolerability; Coronavirus disease 2019 (COVID-19); Pharmacokinetics; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Monoclonal antibody; 2019-20 coronavirus outbreak; Pharmacology; Antibody; Immunology; Adverse effect; Internal medicine; Infectious disease (medical specialty); Outbreak; Disease","authors":[{"name":"Nanyang Li","is_ca":false},{"name":"Jing Zhang","is_ca":false},{"name":"Wenhong Zhang","is_ca":true},{"name":"Zhongyuan Xu","is_ca":false},{"name":"Xiangcao Yao","is_ca":false},{"name":"Anqi He","is_ca":false},{"name":"Shuyuan Liu","is_ca":false},{"name":"Xiaoyun Ge","is_ca":false},{"name":"Jinxi Liu","is_ca":false},{"name":"Yunfei Li","is_ca":false},{"name":"Cecil Chi‐Keung Chen","is_ca":false},{"name":"Huixia Zhang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05256922252441759,"gpt":0.4732816387254207,"spread":0.4207124162010031,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009935792,0.0005009305,0.0006625095,0.0002077278,0.0002856459,0.0002336036,0.0001888349,0.0004725305,0.0008060505],"category_scores_gemma":[0.0007604354,0.0002741453,0.0005232637,0.0001922829,0.0003623677,0.000275086,0.0001489255,0.0004374872,0.0001522908],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004012754,"about_ca_system_score_gemma":0.0004520079,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001747227,"about_ca_topic_score_gemma":0.002359225,"domain_scores_codex":[0.9996228,0.0001560407,0.00002411044,0.00006072774,0.00008240994,0.00005380447],"domain_scores_gemma":[0.9996803,0.0000643652,0.0001141762,0.00001707051,0.00003955574,0.00008453137],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3137821,0.01278376,0.2068051,0.001280009,0.002041908,0.001064554,0.001364104,0.001919195,0.218081,0.0001693285,0.00165802,0.2390511],"study_design_scores_gemma":[0.03509086,0.3625876,0.5790669,0.00003985972,0.00168971,0.0007611538,0.0002779601,0.002130089,0.0161948,0.00009886284,0.001994343,0.00006773244],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990634,0.0004978224,0.00008415202,0.00002965502,0.000005859703,0.00006830519,0.0000634519,0.000005915143,0.0001814516],"genre_scores_gemma":[0.9992052,0.0002542259,0.0001332771,0.00008480126,0.00002251446,0.00005997377,0.00008181791,0.000001395798,0.0001568644],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001747227,"threshold_uncertainty_score":0.005254626,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}